MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D7475B.26890930"

This document is a Single File Web Page, also known as a Web Archive file.  If you are seeing this message, your browser or editor doesn't support Web Archive files.  Please download a browser that supports Web Archive.

------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"Adakveo_clean_files/filelist.xml">
<link rel=3DEdit-Time-Data href=3D"Adakveo_clean_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>Adakveo-4874 EN PI</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>EPAR</o:Subject>
  <o:Author>CHMP</o:Author>
  <o:Keywords>Adakveo, INN-crizanlizumab</o:Keywords>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>P Reshma Sagar</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2018-09-25T14:09:00Z</o:LastPrinted>
  <o:Created>2021-05-12T12:48:00Z</o:Created>
  <o:LastSaved>2021-05-12T12:48:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>7214</o:Words>
  <o:Characters>41126</o:Characters>
  <o:Lines>342</o:Lines>
  <o:Paragraphs>96</o:Paragraphs>
  <o:CharactersWithSpaces>48244</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:Classification dt:dt=3D"string">Internal All EMA Staff and Contractors=
 Business Use Only</o:Classification>
  <o:Confidentiality dt:dt=3D"string">Business Use Only</o:Confidentiality>
  <o:ContentTypeId dt:dt=3D"string">0x010100726F91DD1AE57B44B1BCEB7F1056F5D=
0</o:ContentTypeId>
  <o:DM_Author dt:dt=3D"string"></o:DM_Author>
  <o:DM_Authors dt:dt=3D"string"></o:DM_Authors>
  <o:DM_Category dt:dt=3D"string">Product Information</o:DM_Category>
  <o:DM_Creation_Date dt:dt=3D"string">24/07/2020 09:27:01</o:DM_Creation_D=
ate>
  <o:DM_Creator_Name dt:dt=3D"string">Voltz Caroline</o:DM_Creator_Name>
  <o:DM_DocRefId dt:dt=3D"string">EMA/CHMP/392578/2020</o:DM_DocRefId>
  <o:DM_emea_bcc dt:dt=3D"string"></o:DM_emea_bcc>
  <o:DM_emea_cc dt:dt=3D"string"></o:DM_emea_cc>
  <o:DM_emea_doc_category dt:dt=3D"string">General</o:DM_emea_doc_category>
  <o:DM_emea_doc_lang dt:dt=3D"string"></o:DM_emea_doc_lang>
  <o:DM_emea_doc_number dt:dt=3D"string">423415</o:DM_emea_doc_number>
  <o:DM_emea_doc_ref_id dt:dt=3D"string">EMA/CHMP/392578/2020</o:DM_emea_do=
c_ref_id>
  <o:DM_emea_from dt:dt=3D"string"></o:DM_emea_from>
  <o:DM_emea_internal_label dt:dt=3D"string">EMA</o:DM_emea_internal_label>
  <o:DM_emea_legal_date dt:dt=3D"string">nulldate</o:DM_emea_legal_date>
  <o:DM_emea_meeting_action dt:dt=3D"string"></o:DM_emea_meeting_action>
  <o:DM_emea_meeting_flags dt:dt=3D"string"></o:DM_emea_meeting_flags>
  <o:DM_emea_meeting_hyperlink dt:dt=3D"string"></o:DM_emea_meeting_hyperli=
nk>
  <o:DM_emea_meeting_ref dt:dt=3D"string"></o:DM_emea_meeting_ref>
  <o:DM_emea_meeting_status dt:dt=3D"string"></o:DM_emea_meeting_status>
  <o:DM_emea_meeting_title dt:dt=3D"string"></o:DM_emea_meeting_title>
  <o:DM_emea_message_subject dt:dt=3D"string"></o:DM_emea_message_subject>
  <o:DM_emea_received_date dt:dt=3D"string">nulldate</o:DM_emea_received_da=
te>
  <o:DM_emea_resp_body dt:dt=3D"string"></o:DM_emea_resp_body>
  <o:DM_emea_revision_label dt:dt=3D"string"></o:DM_emea_revision_label>
  <o:DM_emea_sent_date dt:dt=3D"string">nulldate</o:DM_emea_sent_date>
  <o:DM_emea_to dt:dt=3D"string"></o:DM_emea_to>
  <o:DM_emea_year dt:dt=3D"string">2010</o:DM_emea_year>
  <o:DM_Keywords dt:dt=3D"string"></o:DM_Keywords>
  <o:DM_Language dt:dt=3D"string"></o:DM_Language>
  <o:DM_Modifer_Name dt:dt=3D"string">Sofocleous Daphne</o:DM_Modifer_Name>
  <o:DM_Modified_Date dt:dt=3D"string">24/07/2020 12:06:06</o:DM_Modified_D=
ate>
  <o:DM_Modifier_Name dt:dt=3D"string">Sofocleous Daphne</o:DM_Modifier_Nam=
e>
  <o:DM_Modify_Date dt:dt=3D"string">24/07/2020 12:06:06</o:DM_Modify_Date>
  <o:DM_Name dt:dt=3D"string">Adakveo-4874 EN PI</o:DM_Name>
  <o:DM_Owner dt:dt=3D"string">Espinasse Claire</o:DM_Owner>
  <o:DM_Path dt:dt=3D"string">/01. Evaluation of Medicines/H-C/A-C/Adakveo-=
 004874/03 Evaluation/The Final Opinion</o:DM_Path>
  <o:DM_Status dt:dt=3D"string"></o:DM_Status>
  <o:DM_Subject dt:dt=3D"string"></o:DM_Subject>
  <o:DM_Title dt:dt=3D"string"></o:DM_Title>
  <o:DM_Type dt:dt=3D"string">emea_document</o:DM_Type>
  <o:DM_Version dt:dt=3D"string">1.1,CURRENT</o:DM_Version>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ActionId dt:dt=3D"stri=
ng">e0e44905-dcef-47b2-8108-22e7283ae2f5</o:MSIP_Label_0eea11ca-d417-4147-8=
0ed-01a58412c458_ActionId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Application dt:dt=3D"s=
tring">Microsoft Azure Information Protection</o:MSIP_Label_0eea11ca-d417-4=
147-80ed-01a58412c458_Application>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled dt:dt=3D"strin=
g">True</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Extended_MSFT_Method
   dt:dt=3D"string">Automatic</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a5841=
2c458_Extended_MSFT_Method>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Name dt:dt=3D"string">=
All EMA Staff and Contractors</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a5841=
2c458_Name>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Owner dt:dt=3D"string"=
>caroline.voltz@ema.europa.eu</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a5841=
2c458_Owner>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Parent dt:dt=3D"string=
">afe1b31d-cec0-4074-b4bd-f07689e43d84</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_Parent>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SetDate dt:dt=3D"strin=
g">2020-07-24T07:26:45.5891158Z</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58=
412c458_SetDate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_SiteId>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Application dt:dt=3D"s=
tring">Microsoft Azure Information Protection</o:MSIP_Label_4929bff8-5b33-4=
2aa-95d2-28f72e792cb0_Application>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Enabled dt:dt=3D"strin=
g">True</o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Enabled>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Extended_MSFT_Method
   dt:dt=3D"string">Automatic</o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e7=
92cb0_Extended_MSFT_Method>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Name dt:dt=3D"string">=
Business Use Only</o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Name>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_Owner dt:dt=3D"string"=
>RITCHCA1@novartis.net</o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_O=
wner>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_SetDate dt:dt=3D"strin=
g">2018-09-25T14:08:57.9346539Z</o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72=
e792cb0_SetDate>
  <o:MSIP_Label_4929bff8-5b33-42aa-95d2-28f72e792cb0_SiteId dt:dt=3D"string=
">f35a6974-607f-47d4-82d7-ff31d7dc53a5</o:MSIP_Label_4929bff8-5b33-42aa-95d=
2-28f72e792cb0_SiteId>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_ActionId dt:dt=3D"stri=
ng">e0e44905-dcef-47b2-8108-22e7283ae2f5</o:MSIP_Label_afe1b31d-cec0-4074-b=
4bd-f07689e43d84_ActionId>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Application dt:dt=3D"s=
tring">Microsoft Azure Information Protection</o:MSIP_Label_afe1b31d-cec0-4=
074-b4bd-f07689e43d84_Application>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Enabled dt:dt=3D"strin=
g">True</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Enabled>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Extended_MSFT_Method
   dt:dt=3D"string">Automatic</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e=
43d84_Extended_MSFT_Method>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Name dt:dt=3D"string">=
Internal</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Name>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Owner dt:dt=3D"string"=
>caroline.voltz@ema.europa.eu</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e=
43d84_Owner>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_SetDate dt:dt=3D"strin=
g">2020-07-24T07:26:45.5891158Z</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f0768=
9e43d84_SetDate>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_afe1b31d-cec0-4074-b4b=
d-f07689e43d84_SiteId>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"Adakveo_clean_files/item0001.xml"
target=3D"Adakveo_clean_files/props002.xml">
<link rel=3DdataStoreItem href=3D"Adakveo_clean_files/item0003.xml"
target=3D"Adakveo_clean_files/props004.xml">
<link rel=3DdataStoreItem href=3D"Adakveo_clean_files/item0005.xml"
target=3D"Adakveo_clean_files/props006.xml">
<link rel=3DdataStoreItem href=3D"Adakveo_clean_files/item0007.xml"
target=3D"Adakveo_clean_files/props008.xml">
<link rel=3DthemeData href=3D"Adakveo_clean_files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"Adakveo_clean_files/colorschememappi=
ng.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:DoNotUseHTMLParagraphAutoSpacing/>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:Registered>-1</w:Registered>
   <w:Version>0</w:Version>
  </w:DocumentVariables>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" LatentStyleCount=3D"376">
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 9"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"annotation text=
"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"caption"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   Name=3D"Placeholder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true" Name=
=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"\FF2D\FF33 \660E\671D";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;
	mso-font-alt:\65B0\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-alt:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Times New Roman Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"\@PMingLiU";
	panose-1:2 1 6 1 0 1 1 1 1 1;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h6
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:6;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:7;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-unhide:no;
	mso-style-link:"Footnote Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-name:"Comment Text\, Car17\, Car17 Car\,- H19\,Annotationtext\,=
Car17\,Car6\,Char\,Char Char Char\,Char Char1\,Comment Text Char Char\,Comm=
ent Text Char Char Char\,Comment Text Char Char1\,Comment Text Char1\,Comme=
nt Text Char1 Char\,Comment Text Char2 Char\,Kommentartext";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Comment Text Char\, Car17 Char\, Car17 Car Char\,- H19 Cha=
r\,Annotationtext Char\,Car17 Char\,Car6 Char\,Char Char\,Char Char Char Ch=
ar\,Char Char1 Char\,Comment Text Char Char Char1\,Comment Text Char Char C=
har Char\,Comment Text Char Char1 Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 207.65pt right 415.3pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 3.15in right 415.3pt;
	font-size:8.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-no-proof:yes;}
span.MsoFootnoteReference
	{mso-style-unhide:no;
	mso-style-parent:"";
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoEndnoteReference
	{mso-style-unhide:no;
	mso-style-parent:"";
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-unhide:no;
	mso-style-link:"Endnote Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:green;
	mso-ansi-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
a:link, span.MsoHyperlink
	{mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-unhide:no;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Plain Text Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:ZH-CN;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-unhide:no;
	mso-style-parent:"Comment Text\, Car17\, Car17 Car\,- H19\,Annotationtext\=
,Car17\,Car6\,Char\,Char Char Char\,Char Char1\,Comment Text Char Char\,Com=
ment Text Char Char Char\,Comment Text Char Char1\,Comment Text Char1\,Comm=
ent Text Char1 Char\,Comment Text Char2 Char\,Kommentartext";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text\, Car17\, Car17 Car\,- H19\,Annotationtext\,C=
ar17\,Car6\,Char\,Char Char Char\,Char Char1\,Comment Text Char Char\,Comme=
nt Text Char Char Char\,Comment Text Char Char1\,Comment Text Char1\,Commen=
t Text Char1 Char\,Comment Text Char2 Char\,Kommentartext";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-line-height-alt:6.0pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body text \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"Drafting Notes \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:"Times New Roman";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Drafting Notes \(Agency\)";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:"Courier New";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAg=
ency
	{mso-style-name:"Table heading rows \(Agency\)";
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	mso-style-unhide:no;
	margin:0in;
	line-height:14.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:ZH-CN;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char\, Car17 Char\, Car17 Car Char\,- H19 Ch=
ar\,Annotationtext Char\,Car17 Char\,Car6 Char\,Char Char\,Char Char Char C=
har\,Char Char1 Char\,Comment Text Char Char Char1\,Comment Text Char Char =
Char Char\,Comment Text Char Char1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Text\, Car17\, Car17 Car\,- H19\,Annotationtext\,C=
ar17\,Car6\,Char\,Char Char Char\,Char Char1\,Comment Text Char Char\,Comme=
nt Text Char Char Char\,Comment Text Char Char1\,Comment Text Char1\,Commen=
t Text Char1 Char\,Comment Text Char2 Char\,Kommentartext";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Calibri Light";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 6";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 7";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.Text, li.Text, div.Text
	{mso-style-name:"Text\,Graphic\,Graphic Char Char\,Graphic Char Char Char =
Char Char\,Graphic Char Char Char Char Char Char Char C\,Italic\,JP Body Te=
xt\,Text_10394\,graphics\,non tochic\,notic\,\672C\6587";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Text Char\,Graphic Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:ZH-CN;}
span.TextChar
	{mso-style-name:"Text Char\,Graphic Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Text\,Graphic\,Graphic Char Char\,Graphic Char Char Char C=
har Char\,Graphic Char Char Char Char Char Char Char C\,Italic\,JP Body Tex=
t\,Text_10394\,graphics\,non tochic\,notic\,\672C\6587";
	mso-ansi-font-size:12.0pt;
	font-family:"MS Mincho";
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:ZH-CN;}
p.Table, li.Table, div.Table
	{mso-style-name:"Table\,10 pt\,10 pt  Bold\,9 pt";
	mso-style-unhide:no;
	mso-style-link:"Table Char\,10 pt  Bold Char\,10 pt Char\,9 pt Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	tab-stops:14.2pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";}
span.TableChar
	{mso-style-name:"Table Char\,10 pt  Bold Char\,10 pt Char\,9 pt Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Table\,10 pt\,10 pt  Bold\,9 pt";
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:Arial;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:black;}
p.Comment, li.Comment, div.Comment
	{mso-style-name:Comment;
	mso-style-unhide:no;
	mso-style-link:"Comment Char";
	mso-style-next:"Text\,Graphic\,Graphic Char Char\,Graphic Char Char Char C=
har Char\,Graphic Char Char Char Char Char Char Char C\,Italic\,JP Body Tex=
t\,Text_10394\,graphics\,non tochic\,notic\,\672C\6587";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:#BF30B5;
	mso-fareast-language:ZH-CN;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.CommentChar
	{mso-style-name:"Comment Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Comment;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"MS Mincho";
	mso-fareast-font-family:"MS Mincho";
	color:#BF30B5;
	mso-fareast-language:ZH-CN;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Plain Text";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-fareast-language:ZH-CN;}
p.Dedicatednumber, li.Dedicatednumber, div.Dedicatednumber
	{mso-style-name:Dedicatednumber;
	mso-style-unhide:no;
	margin-top:.5in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-language:ZH-CN;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Endnote Text";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.Listlevel1, li.Listlevel1, div.Listlevel1
	{mso-style-name:"List level 1";
	mso-style-unhide:no;
	mso-style-link:"List level 1 Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:21.25pt;
	text-indent:-21.25pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:ZH-CN;}
span.Listlevel1Char
	{mso-style-name:"List level 1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"List level 1";
	mso-ansi-font-size:12.0pt;
	font-family:"MS Mincho";
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:ZH-CN;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Footnote Text";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.Standard, li.Standard, div.Standard
	{mso-style-name:Standard;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
span.Kommentarzeichen
	{mso-style-name:Kommentarzeichen;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.CommentTextChar2
	{mso-style-name:"Comment Text Char2\,- H19 Char1\,Annotationtext Char1\,Co=
mment Text Char Char Char Char1\,Comment Text Char Char Char2\,Comment Text=
 Char Char1 Char1\,Comment Text Char1 Char Char1\,Comment Text Char1 Char2\=
,Comment Text Char2 Char Char1\,Kommentartext Char";
	mso-style-unhide:no;
	mso-style-parent:"";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-fareast-font-family:SimSun;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Adakveo_clean_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Adakveo_clean_files/header.htm") =
fcs;
	mso-endnote-separator:url("Adakveo_clean_files/header.htm") es;
	mso-endnote-continuation-separator:url("Adakveo_clean_files/header.htm") e=
cs;
	mso-endnote-numbering-style:arabic;}
@page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;
	mso-header-margin:36.85pt;
	mso-footer-margin:36.85pt;
	mso-title-page:yes;
	mso-footer:url("Adakveo_clean_files/header.htm") f1;
	mso-first-footer:url("Adakveo_clean_files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:-2;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l0:level1
	{mso-level-start-at:0;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l1
	{mso-list-id:590061;
	mso-list-type:hybrid;
	mso-list-template-ids:1023986052 1535403218 938801038 -1762899846 -9515288=
44 994075544 1529226974 2003720850 -16453844 300596942;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2
	{mso-list-id:71199107;
	mso-list-type:hybrid;
	mso-list-template-ids:1009810678 -1584502070 1645009242 50756320 171932425=
2 1075713720 -797430940 180017874 1557969762 953606614;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3
	{mso-list-id:72942370;
	mso-list-type:simple;
	mso-list-template-ids:-1460387854;}
@list l3:level1
	{mso-level-text:"Figure\: %1\. ";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l4
	{mso-list-id:163859649;
	mso-list-type:hybrid;
	mso-list-template-ids:2146616686 1432882872 542659318 323402168 1067860778=
 567937892 1518509154 -343524500 -161984132 1809458852;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5
	{mso-list-id:196234741;
	mso-list-type:hybrid;
	mso-list-template-ids:161219752 -723359500 -810536034 2129438354 -11375433=
12 -2146256116 1307214346 951227564 892483400 784875106;}
@list l5:level1
	{mso-level-text:"%1\.\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l5:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;
	mso-bidi-font-family:"Times New Roman";}
@list l6
	{mso-list-id:221411970;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l6:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l7
	{mso-list-id:542013103;
	mso-list-template-ids:-311163578;}
@list l7:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l7:level2
	{mso-level-start-at:2;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l7:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l7:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l7:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l7:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l7:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l7:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l7:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l8
	{mso-list-id:557866339;
	mso-list-type:hybrid;
	mso-list-template-ids:-1224971964 931029614 -2044181966 -937662206 -201916=
 1067629210 559060548 1173781572 -1680321758 -1584603030;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:46.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:118.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:154.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:190.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:226.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:262.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:298.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:334.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9
	{mso-list-id:559949466;
	mso-list-type:hybrid;
	mso-list-template-ids:1452601990 700994338 -1448300212 1206451380 15142231=
2 1157660010 -794808146 -231677958 313924810 -655441888;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:46.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:118.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:154.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:190.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:226.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:262.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:298.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:334.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10
	{mso-list-id:667754826;
	mso-list-type:hybrid;
	mso-list-template-ids:-1798276970 546108730 1948439502 424548598 24444374 =
-1330199606 -1691441440 1618798646 576197160 -483914708;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11
	{mso-list-id:758065442;
	mso-list-type:hybrid;
	mso-list-template-ids:1554810642 -1405743910 1948670624 631687174 53125440=
 -954164914 -211485574 1922312186 442893152 -1234685302;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:46.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:118.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:154.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:190.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:226.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:262.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:298.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:334.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12
	{mso-list-id:773020633;
	mso-list-type:hybrid;
	mso-list-template-ids:-623460128 1860175854 -1413598586 -1945983062 -10456=
61894 1741849628 -1184576786 -1586984860 34927220 -483753568;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:19.85pt;
	mso-level-number-position:left;
	margin-left:19.85pt;
	text-indent:-19.85pt;
	font-family:Symbol;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13
	{mso-list-id:777262601;
	mso-list-type:hybrid;
	mso-list-template-ids:509258728 1962999580 1630673902 -504184178 134720867=
8 -1969865440 1061612334 -847239636 -879986662 -312694832;}
@list l13:level1
	{mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l13:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l13:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l13:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l13:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l13:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l13:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l13:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l13:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l14
	{mso-list-id:849955280;
	mso-list-type:hybrid;
	mso-list-template-ids:1479813978 274077950 754493068 -904738982 -212674357=
4 -1436115024 -1960158260 -111798242 -1190754064 -567239676;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15
	{mso-list-id:915288275;
	mso-list-template-ids:-2011128472;}
@list l15:level1
	{mso-level-start-at:6;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l15:level2
	{mso-level-start-at:5;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l15:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l15:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l15:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l15:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l15:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l15:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l15:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l16
	{mso-list-id:962421837;
	mso-list-type:hybrid;
	mso-list-template-ids:1543566246 -699219384 -624147202 621824592 150471296=
2 -1588432556 526299286 -407982978 216809168 -67628754;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17
	{mso-list-id:1032655438;
	mso-list-type:hybrid;
	mso-list-template-ids:-887162576 -2103703174 -13441370 776385030 116663914=
 267674 260207224 -635387480 -889175166 636530724;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18
	{mso-list-id:1047798480;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:14.15pt;
	mso-level-legacy-space:0in;
	margin-left:14.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;}
@list l19
	{mso-list-id:1054046299;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l19:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l20
	{mso-list-id:1085957060;
	mso-list-type:hybrid;
	mso-list-template-ids:-1356179038 1775679548 -2082721008 1846155118 565760=
914 1179172350 1490457800 1053747228 320639740 2021528140;}
@list l20:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21
	{mso-list-id:1104231269;
	mso-list-type:hybrid;
	mso-list-template-ids:-1932638076 1643705522 6877342 -2147482100 129265269=
4 424159592 -155286042 1323486152 1845678766 -661996348;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22
	{mso-list-id:1171725637;
	mso-list-type:hybrid;
	mso-list-template-ids:157595366 -640797632 -434578904 -515215232 122149379=
6 -77663062 -895188532 -695596462 1163136506 1916204316;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23
	{mso-list-id:1249968153;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l23:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l24
	{mso-list-id:1443644261;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l24:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l25
	{mso-list-id:1488284787;
	mso-list-type:hybrid;
	mso-list-template-ids:1537483048 720795038 -1562616448 -1862788440 -326362=
06 -2050444210 -2098446742 -1300365052 1274442262 985826208;}
@list l25:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l26
	{mso-list-id:1569029055;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l26:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l27
	{mso-list-id:1680696663;
	mso-list-template-ids:509258728;}
@list l27:level1
	{mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l27:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l27:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l27:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l27:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l27:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l27:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l27:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l27:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l28
	{mso-list-id:1703674529;
	mso-list-type:simple;
	mso-list-template-ids:-405659258;}
@list l28:level1
	{mso-level-number-format:roman-upper;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l29
	{mso-list-id:1747220272;
	mso-list-type:simple;
	mso-list-template-ids:1620494122;}
@list l29:level1
	{mso-level-start-at:5;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l30
	{mso-list-id:1776900692;
	mso-list-type:hybrid;
	mso-list-template-ids:1008267184 1433324374 1366580974 1353234374 -1152205=
496 -88545010 -2044564480 -726506472 -1963413386 183564754;}
@list l30:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:19.85pt;
	mso-level-number-position:left;
	margin-left:19.85pt;
	text-indent:-19.85pt;
	font-family:Symbol;}
@list l30:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31
	{mso-list-id:1778403230;
	mso-list-type:hybrid;
	mso-list-template-ids:-1959616154 1103006162 -614183308 172929508 -2120261=
04 1301588858 444217868 1887218708 -15144174 -895028572;}
@list l31:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l31:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l31:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l31:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l31:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l31:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l32
	{mso-list-id:1795246133;
	mso-list-template-ids:-810765714;}
@list l32:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l32:level2
	{mso-level-start-at:8;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l32:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l32:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l32:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l32:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l32:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l32:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l32:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l33
	{mso-list-id:1837527551;
	mso-list-type:hybrid;
	mso-list-template-ids:871284816 -1025087812 -1346310438 -600941908 -854176=
010 -1315153132 -1425625432 126282084 1388770828 -830973722;}
@list l33:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l33:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l33:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l33:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l33:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l33:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l33:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l33:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l33:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l34
	{mso-list-id:1838421848;
	mso-list-type:simple;
	mso-list-template-ids:-1735361676;}
@list l34:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-weight:bold;}
@list l35
	{mso-list-id:1866089568;
	mso-list-type:hybrid;
	mso-list-template-ids:-1238993736 -1234764952 1432798062 -388958892 106877=
1362 -160767746 166767476 57291468 1006562988 -134468972;}
@list l35:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l35:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l35:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l35:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l35:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l35:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l35:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l35:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l36
	{mso-list-id:1871919056;
	mso-list-type:hybrid;
	mso-list-template-ids:-1228372506 1052519906 -1383014442 -1425098486 66899=
7380 1713387868 -832658216 -2060148258 1875136220 -547444530;}
@list l36:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l36:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l36:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l36:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l36:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l36:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l36:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l36:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l36:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l37
	{mso-list-id:1923830001;
	mso-list-type:hybrid;
	mso-list-template-ids:1691264716 71488910 1440508218 1286626748 1674710296=
 -1672994188 344905078 -1548830040 1570012134 -1287883732;}
@list l37:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l37:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l37:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l38
	{mso-list-id:2020764974;
	mso-list-template-ids:-311163578;}
@list l38:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l38:level2
	{mso-level-start-at:2;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l38:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l38:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l38:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l38:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l38:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l38:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l38:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l39
	{mso-list-id:2085640743;
	mso-list-type:hybrid;
	mso-list-template-ids:-861257720 -1256275006 1687715060 127067274 32616992=
8 1302120714 508431334 -111354322 1242457142 -416242438;}
@list l39:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40
	{mso-list-id:2147161103;
	mso-list-type:hybrid;
	mso-list-template-ids:1317320460 -1192597634 -1484748842 -2014426728 -1646=
095566 -2039419008 -1549512716 -591525062 407668166 -1565245786;}
@list l40:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level1 lfo3
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l0:level1 lfo4
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level1 lfo15
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.TablegridAgencyblack
	{mso-style-name:"Table grid \(Agency\) black";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid windowtext;
	mso-border-insidev:.75pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Verdana",sans-serif;}
table.TablegridAgencyblackFirstRow
	{mso-style-name:"Table grid \(Agency\) black";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-tstyle-border-top:.5pt solid windowtext;
	mso-tstyle-border-left:.5pt solid windowtext;
	mso-tstyle-border-bottom:.5pt solid windowtext;
	mso-tstyle-border-right:.5pt solid windowtext;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:.75pt solid windowtext;
	mso-tstyle-border-insidev:.75pt solid windowtext;
	font-size:9.0pt;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	color:windowtext;
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
table.NormaleTabelle
	{mso-style-name:"Normale Tabelle";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
  <o:rules v:ext=3D"edit">
   <o:r id=3D"V:Rule1" type=3D"connector" idref=3D"#Straight_x0020_Connecto=
r_x0020_1355"/>
   <o:r id=3D"V:Rule2" type=3D"connector" idref=3D"#Straight_x0020_Connecto=
r_x0020_1356"/>
  </o:rules>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3D"#954F72" style=3D'tab-interval:28.3=
5pt;
word-wrap:break-word'>

<div class=3DWordSection1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>ANNEX I</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>SUMMARY OF PRODUCT CHARACT=
ERISTICS</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;font=
-family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";color:gre=
en;
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'><v:shapetype id=3D"_x000=
0_t75"
 coordsize=3D"21600,21600" o:spt=3D"75" o:preferrelative=3D"t" path=3D"m@4@=
5l@4@11@9@11@9@5xe"
 filled=3D"f" stroked=3D"f">
 <v:stroke joinstyle=3D"miter"/>
 <v:formulas>
  <v:f eqn=3D"if lineDrawn pixelLineWidth 0"/>
  <v:f eqn=3D"sum @0 1 0"/>
  <v:f eqn=3D"sum 0 0 @1"/>
  <v:f eqn=3D"prod @2 1 2"/>
  <v:f eqn=3D"prod @3 21600 pixelWidth"/>
  <v:f eqn=3D"prod @3 21600 pixelHeight"/>
  <v:f eqn=3D"sum @0 0 1"/>
  <v:f eqn=3D"prod @6 1 2"/>
  <v:f eqn=3D"prod @7 21600 pixelWidth"/>
  <v:f eqn=3D"sum @8 21600 0"/>
  <v:f eqn=3D"prod @7 21600 pixelHeight"/>
  <v:f eqn=3D"sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok=3D"f" gradientshapeok=3D"t" o:connecttype=3D"rect"/>
 <o:lock v:ext=3D"edit" aspectratio=3D"t"/>
</v:shapetype><v:shape id=3D"_x0000_i1027" type=3D"#_x0000_t75" style=3D'wi=
dth:15.75pt;
 height:13.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src=3D"Adakveo_clean_files/image001.png" o:title=3D"BT_1000x8=
58px"/>
</v:shape></span><span lang=3DEN-GB>This medicinal product is subject to
additional monitoring. This will allow quick identification of new safety
information. Healthcare professionals are asked to report any suspected adv=
erse
reactions. See section&nbsp;4.8 for how to report adverse reactions.</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-hyphenate:none;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span>NA=
ME OF </span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>THE<span style=3D'mso-no-proof:yes'> MEDICINAL PRODUCT</span></span=
></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>Adakveo 10&nbsp;mg/ml concentrate for solution for infusi=
on<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-hyphenate:none;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'> </span>QU=
ALITATIVE
AND QUANTITATIVE COMPOSITION</span></b><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Each ml of concentrate for
solution for infusion contains 10&nbsp;mg crizanlizumab.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>One vial of 10&nbsp;ml con=
tains
100&nbsp;mg crizanlizumab.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Crizanlizumab is a monoclo=
nal
antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA
technology.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>F<span
style=3D'mso-no-proof:yes'>or the full list of excipients, see section&nbsp=
;6.1.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-hyphenate:none;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span>PH=
ARMACEUTICAL
</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Times New Roman Bold",serif;
mso-no-proof:yes'>FORM</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;text-transform:uppercase;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><a
name=3D"_Toc259706902"></a><a name=3D"_Toc259707071"></a><a name=3D"_Toc259=
707134"></a><a
name=3D"_Toc259713075"><span style=3D'mso-bookmark:_Toc259707134'><span
style=3D'mso-bookmark:_Toc259707071'><span style=3D'mso-bookmark:_Toc259706=
902'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Concentra=
te for solution
for infusion</span></span></span></span></a><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'> (sterile concentrate)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Colourles=
s to
slightly brownish&#8209;yellow liquid at pH&nbsp;6 and with an osmolality of
300&nbsp;mOsm/kg.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-hyphenate:none;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;text-transform:uppercase;mso-no-proof:yes'>4.<span style=3D'mso-tab-=
count:
1'> </span></span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>CLINICAL<=
/span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;font-family:"Times New Roman Bold",serif;mso-no-proof:yes'> PARTICUL=
ARS</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transform:uppercase;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.1<span style=3D'mso-tab-count:1'> </span>The=
rapeutic
indications</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'>Adakveo</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> is indicated for the prev=
ention
of recurrent vaso&#8209;occlusive crises (VOCs) in sickle cell disease pati=
ents
aged 16&nbsp;years and older. <span style=3D'mso-no-proof:yes'>It can be gi=
ven as
an add&#8209;on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as
monotherapy in patients for whom HU/HC is inappropriate or inadequate.</spa=
n><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.2<span style=3D'mso-=
tab-count:
1'> </span>Posology and method of administration</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Treatment
should be initiated by physicians experienced in the management of </span><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>sickle cell disease<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Posology=
</span></u><a
name=3D"_nth_Adults_and_patients_ag4131"></a><span lang=3DEN-GB style=3D'ms=
o-bidi-font-size:
11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>The recommended dose of <s=
pan
style=3D'mso-bidi-font-style:italic;mso-no-proof:yes'>crizanlizumab</span> =
is
5&nbsp;mg/kg administered over a period of 30&nbsp;minutes by intravenous
infusion at week&nbsp;0, week&nbsp;2, and every 4&nbsp;weeks thereafter.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic;mso-no-proof:yes'>Crizanlizumab </span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>c</span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'>an be given alone or with HU/HC.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;page-break-after:avoid;mso-=
outline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If a
dose is missed, the treatment should be administered as soon as possible.<o=
:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l35 level1 lfo41'><![if !supportLists]><span style=3D'font-size:11=
.0pt;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>If crizanli=
zumab is
administered within 2&nbsp;weeks after the missed dose, dosing should be
continued according to the patients original schedule.<o:p></o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l35 level1 lfo41'><![if !supportLists]><span style=3D'font-size:11=
.0pt;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>If crizanli=
zumab is
administered more than 2&nbsp;weeks after the missed dose, dosing should be
continued every 4&nbsp;weeks thereafter.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Special populations</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-=
font-weight:
bold'>Elderly<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Crizanlizumab has not been=
 studied
in elderly patients. No dose adjustment is required as the pharmacokinetics=
 of
crizanlizumab in adults are not affected by age.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Renal impairment<o:p></o:p></span></i><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Based on the population
pharmacokinetic (PK) results, no dose adjustment is required in patients wi=
th
mild or moderate renal impairment (see section&nbsp;5.2). Data from patients
with severe renal impairment are too limited to draw conclusions on this
population.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Hepatic impairment<o:p></o:p></span></i=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>The safety and efficacy of=
 crizanlizumab
in patients with hepatic impairment have not been established. Crizanlizuma=
b is
a monoclonal antibody and is cleared via catabolism (i.e. breakdown into
peptides and amino acids), and a change in dose is not expected to be requi=
red
for patients with hepatic impairment (see section</span><span lang=3DEN-GB
style=3D'font-size:10.0pt;mso-bidi-font-size:11.0pt'>&nbsp;</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>5.2).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-=
font-weight:
bold'>Paediatric population</span></i><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p></s=
pan></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-=
style:
italic'>The safety and efficacy of </span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;mso-bidi-font-style:italic;mso-no-proof:yes'>crizanlizumab</span><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-bidi-font-style:italic'> in paediatric patients from 6&nbsp;months to
16&nbsp;years have not been established. No data are available.<o:p></o:p><=
/span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-=
style:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-=
style:
italic'>There is no relevant use of crizanlizumab in infants aged less than
6&nbsp;months for the indication of prevention of recurrent vaso&#8209;occl=
usive
crises.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Method of
administration</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>Adakveo </span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt'>should be diluted with sodium chloride 9&nbsp;mg/ml (0.9%) solution=
 for
injection or dextrose 5% before administration.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>The diluted solution</span><span lang=3DEN-GB style=3D'ms=
o-bidi-font-size:
11.0pt'> must be administered through a sterile, non&#8209;pyrogenic 0.2&nb=
sp;micron
in&#8209;line filter by intravenous infusion over a period of 30&nbsp;minut=
es. It
must not be administered by intravenous push or bolus.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For instructions on diluti=
on of the
medicinal product before administration, see section&nbsp;6.6.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.3<span
style=3D'mso-tab-count:1'> </span>Contraindications</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Hypersens=
itivity
to the active substance or to any of the excipients listed in section&nbsp;=
6.1.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Hypersens=
itivity
to Chinese Hamster Ovary (CHO) cell products.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.4<span
style=3D'mso-tab-count:1'> </span>Special warnings and precautions for =
use</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Traceabi=
lity<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>In order =
to
improve the traceability of biological medicinal products, the name and the
batch number of the administered product should be clearly recorded.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Infusion=
&#8209;related
reactions</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>In clinic=
al
studies, infusion&#8209;related reactions (defined as occurring within
24&nbsp;hours) were observed in 2&nbsp;patients (1.8%) treated with <span
style=3D'mso-bidi-font-style:italic'>crizanlizumab </span>5&nbsp;mg/kg</spa=
n><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>. <span style=3D'mso-no-pr=
oof:yes'>Patients
should be monitored for signs and symptoms of infusion&#8209;related reacti=
ons,
</span>which may include fever, chills, nausea, vomiting, fatigue, dizzines=
s,
pruritus, urticaria, sweating, shortness of breath or wheezing<span
style=3D'mso-no-proof:yes'>. </span></span><span lang=3DEN-GB style=3D'mso-=
no-proof:
yes'>In the event of a severe reaction, crizanlizumab should be discontinued
and appropriate therapy should be instituted.</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Laborato=
ry test
interference: automated platelet counts</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Interfere=
nce with
automated platelet counts (platelet clumping) has been observed in patients
treated with crizanlizumab in clinical studies, in particular when tubes
containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead =
to
unevaluable or falsely decreased platelet counts. There is no evidence that=
 crizanlizumab
causes a reduction in circulating platelets or has a pro&#8209;aggregant ef=
fect
<i style=3D'mso-bidi-font-style:normal'>in vivo</i>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>To mitiga=
te the
potential for laboratory test interference, it is recommended to run the te=
st as
soon as possible (within 4&nbsp;hours of blood collection) or use citrate
tubes. When needed, </span><span lang=3DEN-GB>platelet counts can be estima=
ted via
a peripheral blood smear</span><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Excipien=
ts with
known effect</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>This medi=
cine
contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per vial, that is to say
essentially sodium&#8209;free.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.5<span style=3D'mso-tab-count:1'> </span>Int=
eraction
with other medicinal products and other forms of interaction</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Interacti=
ons
between crizanlizumab and other medicinal products have not been investigat=
ed
in dedicated studies.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Monoclonal
antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefo=
re,
medicinal products that are substrates, inhibitors or inducers of CYP450 are
not expected to affect the pharmacokinetics of crizanlizumab. In clinical
studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>No effect=
 on
exposure of co&#8209;administered medicinal products is expected based on t=
he
metabolic pathways of monoclonal antibodies.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.6<span style=3D'mso-tab-count:1'> </span></s=
pan></b><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Fertility, p</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>regnancy and lactation</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Pregnancy</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;m=
so-no-proof:
yes'>There is a limited amount of data from the use of Adakveo in pregnant
women. Based on data from animal studies, crizanlizumab has the potential to
cause foetal losses when administered to a pregnant woman (see
section&nbsp;5.3). As a precautionary measure, it is preferable to avoid the
use of Adakveo during pregnancy and in woman of childbearing potential not
using contraception.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>To
help determine the effects in pregnant women, healthcare professionals are
encouraged to report all pregnancy cases and complications during pregnancy
(from 105&nbsp;days prior to the last menstrual period onward) to </span><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>the local
representative of the</span><span style=3D'mso-bidi-font-size:11.0pt;mso-an=
si-language:
EN-US;mso-no-proof:yes'> marketing authorisation holder (see package leafle=
t), </span><span
style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'>in order to allow monito=
ring
of these patients through the PRegnancy outcomes Intensive Monitoring progr=
amme
(PRIM). In addition, all adverse pregnancy events should be reported </span=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>via <span style=3D'color:b=
lack;
mso-color-alt:windowtext;background:#D9D9D9;mso-shading:windowtext;mso-patt=
ern:
gray-15 auto'>the national reporting system listed in </span></span><span
lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'mso-bidi-font-size:11.0pt;background:#D9D9D9;mso-shading:windowtex=
t;
mso-pattern:gray-15 auto'>Appendix V</span></a></span><span style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes'>.</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Breast&#8209;feeding</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB>It is unknown whether crizanlizumab is excreted in human milk =
after
administration of Adakveo. There are no data on the effects of crizanlizuma=
b on
the breast&#8209;fed newborn/infant or on milk production.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Because m=
any
medicinal products, including antibodies, can be excreted in human milk, a =
risk
to the newborn/infant cannot be excluded.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>A decisio=
n must
be made whether to discontinue breast&#8209;feeding or to discontinue Adakv=
eo
therapy, taking into account the benefit of breast&#8209;feeding for the ch=
ild
and the benefit of therapy for the woman.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Fertility</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>There are=
 no data
on the effect of Adakveo on human fertility. Available non&#8209;clinical d=
ata
do not suggest an effect on fertility under crizanlizumab treatment (see
section&nbsp;5.3).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.7<span style=3D'mso-tab-count:1'> </span>Eff=
ects
on ability to drive and use machines</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo m=
ay have
a minor influence on the ability to drive and use machines. Dizziness, fati=
gue
and somnolence may occur following administration of crizanlizumab.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.8<span style=3D'mso-=
tab-count:
1'> </span>Undesirable effects</span></b><span lang=3DEN-GB style=3D'ms=
o-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Summary of the safety
profile</span></u><a name=3D"_nth_Summary_of_the_safety_6118"></a><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'>The most frequently reported adverse drug reactions
(&#8805;10% of patients) in the <span style=3D'mso-bidi-font-style:italic'>=
Adakveo</span>
5&nbsp;mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal
pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Tabulated list of adve=
rse
reactions</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Table&nbsp;1
lists adverse reactions based on pooled data from two studies: the pivotal
study, SUSTAIN, and a single&#8209;arm, open&#8209;label
pharmacokinetics/pharmacodynamics and safety study<span style=3D'mso-no-pro=
of:
yes'>. Use of crizanlizumab in combination with HU/HC did not result in any
meaningful differences in the safety profile.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'>Within each system organ class, the adverse reactions are
ranked by frequency, with the most frequent reactions first. Within each
frequency grouping, adverse reactions are presented in order of decreasing
seriousness. In addition, the corresponding frequency category for each adv=
erse
reaction is based on the following convention: very common (&#8805;1/10);
common (&#8805;1/100 to &lt;1/10); uncommon (&#8805;1/1,000 to &lt;1/100); =
rare
(&#8805;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:ye=
s'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><a name=3D"_Toc2721=
45403"></a><a
name=3D"_Toc272145564"></a><a name=3D"_Toc266768477"></a><a name=3D"_Toc260=
903679"></a><a
name=3D"_Toc266264818"></a><a name=3D"_Toc499550967"></a><a name=3D"_Toc517=
716325"><span
style=3D'mso-bookmark:_Toc499550967'><span style=3D'mso-bookmark:_Toc266264=
818'><span
style=3D'mso-bookmark:_Toc260903679'><span style=3D'mso-bookmark:_Toc266768=
477'><span
style=3D'mso-bookmark:_Toc272145564'><span style=3D'mso-bookmark:_Toc272145=
403'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>Table&nbsp;1<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-bidi-font-weight:bold'>Adverse reactions in clinical st</span>=
udies</span></b></span></span></span></span></span></span></a><span
style=3D'mso-bookmark:_Toc272145403'></span><span style=3D'mso-bookmark:_To=
c272145564'></span><span
style=3D'mso-bookmark:_Toc266768477'></span><span style=3D'mso-bookmark:_To=
c260903679'></span><span
style=3D'mso-bookmark:_Toc266264818'></span><span style=3D'mso-bookmark:_To=
c499550967'></span><span
style=3D'mso-bookmark:_Toc517716325'></span><a
name=3D"_hd6_Table_7_1_Percentage_o7395"></a><span lang=3DEN-GB style=3D'ms=
o-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D612
 style=3D'width:459.0pt;border-collapse:collapse;border:none;mso-border-alt=
:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D234 valign=3Dtop style=3D'width:175.5pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;page-break-after:avoid'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>System organ class<o:p></o:p></span></b></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;page-break-after:avoid'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>Frequency<o:p></o:p></span></b></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;page-break-after:avoid'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>Adverse reaction<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D234 valign=3Dtop style=3D'width:175.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Respiratory,
  thoracic and mediastinal disorders<o:p></o:p></span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB;
  mso-no-proof:yes'>Oropharyngeal pain</span><span lang=3DEN-GB style=3D'fo=
nt-size:
  11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D234 rowspan=3D2 valign=3Dtop style=3D'width:175.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Gastrointestinal
  disorders<o:p></o:p></span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Very
  common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Nausea,
  abdominal pain*<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid;height:13.45pt'>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.45pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.45pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB;
  mso-no-proof:yes'>D</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
  mso-ansi-language:EN-GB'>iarrhoea,<span style=3D'mso-no-proof:yes'> vomit=
ing</span><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D234 valign=3Dtop style=3D'width:175.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Skin
  and subcutaneous tissue disorders<o:p></o:p></span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Pruritus*<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D234 rowspan=3D2 valign=3Dtop style=3D'width:175.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Musculoskeletal
  and connective tissue disorders<o:p></o:p></span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Very
  common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Arthralgia,
  back pain<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Myalgia,
  musculoskeletal chest pain<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D234 rowspan=3D2 valign=3Dtop style=3D'width:175.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>General
  disorders and administration site conditions<o:p></o:p></span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Very
  common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Pyrexia<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Infusion
  site reaction*<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D234 valign=3Dtop style=3D'width:175.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Injury,
  poisoning and procedural complications<o:p></o:p></span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D270 valign=3Dtop style=3D'width:202.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page=
-break-after:
  avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-=
GB'>Infusion&#8209;related
  reaction<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D612 colspan=3D3 valign=3Dtop style=3D'width:459.0pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DTable style=3D'margin:0in;mso-pagination:widow-orphan;tab-stop=
s:28.35pt'><span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-langua=
ge:EN-GB'>*The
  following groupings contain the following MedDRA preferred terms:<o:p></o=
:p></span></p>
  <p class=3DTable style=3D'margin-top:0in;margin-right:0in;margin-bottom:0=
in;
  margin-left:28.35pt;text-indent:-28.35pt;mso-pagination:widow-orphan;
  mso-list:l22 level1 lfo28;tab-stops:28.35pt'><![if !supportLists]><span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore=
'>-<span
  style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DEN-GB style=3D'font-family:"T=
imes New Roman",serif;
  mso-ansi-language:EN-GB'>Abdominal pain: abdominal pain, abdominal pain u=
pper,
  abdominal pain lower, abdominal discomfort, and abdominal tenderness<o:p>=
</o:p></span></p>
  <p class=3DTable style=3D'margin-top:0in;margin-right:0in;margin-bottom:0=
in;
  margin-left:28.35pt;text-indent:-28.35pt;mso-pagination:widow-orphan;
  mso-list:l22 level1 lfo28;tab-stops:28.35pt'><![if !supportLists]><span
  lang=3DFR-CH style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:FR-CH'><span style=3D'mso-list:Ignore=
'>-<span
  style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DEN-GB style=3D'font-family:"T=
imes New Roman",serif;
  mso-ansi-language:EN-GB'>Pruritus: pruritus and vulvovaginal pruritus</sp=
an><span
  lang=3DFR-CH style=3D'font-family:"Times New Roman",serif;mso-ansi-langua=
ge:FR-CH'><o:p></o:p></span></p>
  <p class=3DTable style=3D'margin-top:0in;margin-right:0in;margin-bottom:0=
in;
  margin-left:28.35pt;text-indent:-28.35pt;mso-pagination:widow-orphan;
  mso-list:l22 level1 lfo28;tab-stops:28.35pt'><![if !supportLists]><span
  lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",seri=
f;
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'><span
  style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DFR-CH style=3D'font-family:"T=
imes New Roman",serif;
  mso-ansi-language:FR-CH'>Infusion site reaction: infusion site extravasat=
ion,
  infusion site pain, and infusion site swelling</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-ansi-la=
nguage:
  EN-GB'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt'>Description of selected adverse reactio=
ns</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page-b=
reak-after:
avoid'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><u><span style=3D'font-size:=
11.0pt'>Immunogenicity</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'><o:p>=
</o:p></span></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'>In clinical studies, treatment&#8209;induced ant=
i&#8209;crizanlizumab
antibodies were transiently detected in 1&nbsp;patient (0.9%) among the 111=
&nbsp;patients
who received Adakveo 5&nbsp;mg/kg.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'>There was no evidence of altered pharmacokinetic=
s or of
an altered safety profile with anti&#8209;crizanlizumab antibody developmen=
t.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;page-break-after:avoid;tab-=
stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt'>Paediatric population<o:p></o:p></span>=
</u></p>

<p class=3DStandard style=3D'line-height:normal;page-break-after:avoid;tab-=
stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'>Frequency, type and severity of adverse reaction=
s in
patients aged 16 and 17&nbsp;years are expected to be the same as in adults.
The safety of crizanlizumab was evaluated in 3&nbsp;patients aged &lt;18&nb=
sp;years.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of suspected adverse reaction=
s</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspect=
ed
adverse reactions via <span style=3D'color:black;mso-color-alt:windowtext;
background:#D9D9D9;mso-shading:windowtext;mso-pattern:gray-15 auto'>the
national reporting system listed in </span></span><span lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'mso-bidi-font-size:11.0pt;background:#D9D9D9;mso-shading:windowtex=
t;
mso-pattern:gray-15 auto'>Appendix V</span></a></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>.<span style=3D'mso-no-proof:yes'><o:p>=
</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.9<span style=3D'mso-tab-count:1'> </span>Ove=
rdose</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>No cases of overdose h=
ave
been reported in clinical studies.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>General s=
upportive
measures and symptomatic treatment should be initiated in cases of suspected
overdose.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-hyphenate:none;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>PHARMACOLOGICAL
PROPERTIES</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>5.1<span style=3D'mso-tab-count:1'> </span>Pharmacodynamic prop=
erties</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Pharmacotherapeutic
group: <span style=3D'mso-no-proof:yes'>Other haematological agents, ATC co=
de: <span
style=3D'mso-bidi-font-weight:bold'>B06AX01</span><o:p></o:p></span></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt'>Mechanism of action</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Crizanlizumab
is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to=
 P&#8209;selectin
with high affinity and blocks the interaction with its ligands, including P=
&#8209;selectin
glycoprotein ligand&nbsp;1. </span><span lang=3DEN-GB>Crizanlizumab can also
dissociate preformed P&#8209;selectin/PSGL&#8209;1 complex. </span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>P&#8209;selectin is an adh=
esion
molecule expressed on activated endothelial cells and platelets. It plays an
essential role in the initial recruitment of leukocytes and the aggregation=
 of
platelets to the site of vascular injury during inflammation. In the chronic
pro&#8209;inflammatory state associated with sickle cell disease, P&#8209;s=
electin
is over&#8209;expressed and circulating blood cells and the endothelium are
activated and become hyperadhesive. P&#8209;selectin&#8209;mediated multi&#=
8209;cellular
adhesion is a key factor in the pathogenesis of vaso&#8209;occlusion and va=
so&#8209;occlusive
crises (VOC). Elevated levels of P&#8209;selectin are found in patients with
sickle cell disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Binding
P&#8209;selectin on the surface of the activated endothelium and platelets =
has
been shown to effectively block interactions between endothelial cells,
platelets, red blood cells and leukocytes, thereby preventing vaso&#8209;oc=
clusion.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt'>Pharmacodynamic effects</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Throughout clinical studie=
s, treatment
with crizanlizumab 5&nbsp;mg/kg resulted in dose&#8209;dependent, immediate=
 and
sustained P&#8209;selectin inhibition </span><span lang=3DEN-GB>(as measure=
d <i
style=3D'mso-bidi-font-style:normal'>ex vivo</i>) </span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>in patients with sickle cell disease.</=
span><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt'>Clinical efficacy and safety</span></u>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>The
efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivo=
tal
study SUSTAIN, a 52&#8209;week, randomised, placebo&#8209;controlled, doubl=
e&#8209;blind,
multicentre clinical study in sickle cell disease patients with a history o=
f vaso&#8209;occlusive
crises (VOCs).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>In
this study, VOCs were defined as those leading to a healthcare visit, which
captured all acute episodes of pain with no other cause than a vaso&#8209;o=
cclusive
event that required a healthcare visit and treatment with oral or parenteral
opioids or parenteral non&#8209;steroidal anti&#8209;inflammatory drugs
(NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration
and priapism (requiring a healthcare visit), by definition, were also consi=
dered
VOCs.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>A
total of 198&nbsp;sickle cell disease patients aged 16 to 63&nbsp;years
(inclusive; mean age 30.110.3&nbsp;years), with any sickle cell disease ge=
notype
(including HbSS [71.2%], HbSC [16.2%], HbSbeta0&#8209;thalassaemia [6.1%],
HbSbeta+&#8209;thalassaemia [5.1%], and others [1.5%]) and a history of bet=
ween
2 and 10&nbsp;VOCs in the previous 12&nbsp;months (62.6% and 37.4% of the
patients had 2&#8209;4 or 5&#8209;10&nbsp;VOCs, respectively), were randomi=
sed
1:1:1 to <span style=3D'mso-bidi-font-style:italic;mso-no-proof:yes'>Adakve=
o</span>
5&nbsp;mg/kg, <span style=3D'mso-bidi-font-style:italic;mso-no-proof:yes'>A=
dakveo</span>
2.5&nbsp;mg/kg or placebo. The majority of patients were Black or African
American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%)
HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/=
N)
and by number of VOCs in the previous 12&nbsp;months (2 to 4, 5&nbsp;to 10)=
. Patients
were allowed to take medicinal products to relieve pain (i.e. paracetamol,
NSAIDs and opioids) and to receive occasional transfusions on an as needed
basis. Patients participating in a chronic transfusion programme (pre-plann=
ed
series of transfusions for prophylactic purposes) were excluded from the st=
udy.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Treatment
with Adakveo 5&nbsp;mg/kg resulted in a 45.3% lower median annual rate of V=
OCs compared
to placebo (Hodges&#8209;Lehmann, median absolute difference of &#8209;1.01
compared with placebo, 95% CI [&#8209;2.00, 0.00]), which was statistically
significant (p=3D0.010). The median annual rates of uncomplicated VOCs (any=
 VOCs
as defined above, excluding acute chest syndrome, hepatic sequestration,
splenic sequestration or priapism) and days hospitalised were 62.9% and 41.=
8%
lower in the Adakveo 5&nbsp;mg/kg than in the placebo group, respectively. =
The
VOCs occurring during the study were assessed by an independent review
committee.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Main
efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables&nbs=
p;2
and 3.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><a name=3D"_Toc499550968"></a><a name=3D"_Toc517716326"><span
style=3D'mso-bookmark:_Toc499550968'><b><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;mso-no-proof:yes'>Table&nbsp;</span></b></span></a><span
style=3D'mso-bookmark:_Toc517716326'><span style=3D'mso-bookmark:_Toc499550=
968'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>2<span style=3D'mso-tab-count:1'> </span>Res=
ults
from SUSTAIN clinical study in </span></b></span></span><a
name=3D"_hd6_Table_12_1_Results_fro16811"></a><b style=3D'mso-bidi-font-wei=
ght:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>sickle
cell disease</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o=
:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"98%"
 style=3D'width:98.84%;border-collapse:collapse;border:none;mso-border-top-=
alt:
 solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;mso-padd=
ing-alt:
 0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid;
  height:1.0pt'>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.16%;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Event<o:p></o:p></span></b></p>
  </td>
  <td width=3D"23%" valign=3Dtop style=3D'width:23.82%;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Adakveo 5&nbsp;mg/kg</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>(N=3D67)</span></b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(standard
  median)<o:p></o:p></span></p>
  </td>
  <td width=3D"11%" valign=3Dtop style=3D'width:11.54%;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Placebo</span></b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>(N=3D65)</span></b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(standard
  median)<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>
  </td>
  <td width=3D"10%" valign=3Dtop style=3D'width:10.46%;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Change vs placebo<o:p></o:p></span></=
b></p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.1%;border-top:solid wind=
owtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Hodges&#8209;Lehmann
  median difference</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
  mso-bidi-font-weight:bold'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t;
  mso-bidi-font-weight:bold'>(95% CI)</span><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'><o:p></o:p></span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.9%;border-top:solid wind=
owtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>p-value</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold=
'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t;
  mso-bidi-font-weight:bold'>(Wilcoxon rank sum)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Primary endpoint</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Annual
  rate of VOCs<o:p></o:p></span></p>
  </td>
  <td width=3D"23%" valign=3Dtop style=3D'width:23.82%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>1.63<o:p></o:p></span></p>
  </td>
  <td width=3D"11%" valign=3Dtop style=3D'width:11.54%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2.98<o:p></o:p></span></p>
  </td>
  <td width=3D"10%" valign=3Dtop style=3D'width:10.46%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;45.3%<o:p></o:p></span></p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.1%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;1.01<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;2.00,
  0.00)<o:p></o:p></span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.9%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>0.010<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D"87%" colspan=3D5 valign=3Dtop style=3D'width:87.1%;border:no=
ne;
  border-bottom:solid windowtext 1.0pt;mso-border-top-alt:solid windowtext =
.5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Secondary endpoints</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.9%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Annual
  rate of days hospitalised<o:p></o:p></span></p>
  </td>
  <td width=3D"23%" valign=3Dtop style=3D'width:23.82%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>4.00<o:p></o:p></span></p>
  </td>
  <td width=3D"11%" valign=3Dtop style=3D'width:11.54%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>6.87<o:p></o:p></span></p>
  </td>
  <td width=3D"10%" valign=3Dtop style=3D'width:10.46%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;41.8%<o:p></o:p></span></p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.1%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>0.00<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;4.36,
  0.00)<o:p></o:p></span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.9%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>0.450<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Annual
  rate of uncomplicated VOCs<o:p></o:p></span></p>
  </td>
  <td width=3D"23%" valign=3Dtop style=3D'width:23.82%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>1.08<o:p></o:p></span></p>
  </td>
  <td width=3D"11%" valign=3Dtop style=3D'width:11.54%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2.91<o:p></o:p></span></p>
  </td>
  <td width=3D"10%" valign=3Dtop style=3D'width:10.46%;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;62.9%<o:p></o:p></span></p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.1%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;1.00<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;1.98,
  0.00)<o:p></o:p></span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.9%;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>-<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;page-break-inside:avoid;
  height:1.0pt'>
  <td width=3D"0%" colspan=3D6 valign=3Dtop style=3D'width:.02%;border:none=
;border-bottom:
  solid windowtext 1.0pt;mso-border-top-alt:solid windowtext .5pt;mso-borde=
r-top-alt:
  solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-la=
yout-grid-align:
  none;text-autospace:none'><span lang=3DEN-GB style=3D'font-size:10.0pt'>T=
he
  primary (annual rate of VOC leading to healthcare visit) and key secondary
  (annual rate of days hospitalised) endpoints were the only ones formally
  tested for statistical significance according to protocol.<o:p></o:p></sp=
an></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>The clinical effect demonstrated in=
 the
primary efficacy analysis was supported by multiple supplementary analyses
including a negative binomial regression on investigator assessments with a
conservative method to handle missing data due to early discontinuation of
treatment based on outcomes in the placebo group (RR=3D0.74, 95% CI=3D0.52,=
 1.06).</span><span
style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>In
the Adakveo 5&nbsp;mg/kg group, clinically significant reductions in the an=
nual
rate of VOCs were observed across important subgroups (</span><span lang=3D=
EN-GB>HU/HC
use, 2&#8209;4 or 5&#8209;10&nbsp;VOCs in the previous 12&nbsp;months, and =
HbSS
or non&#8209;HbSS genotypes; </span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>see Table&nbsp;3).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Table&nbsp;3<span style=3D'mso-tab-count:1'> </span>Annual ra=
te of
VOCs in patients &#8209; subgroup analyses</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o=
:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D612
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windo=
wtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D121 valign=3Dtop style=3D'width:90.45pt;border-top:solid wind=
owtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Subgroup <o:p></o:p></span></b></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border-top:solid window=
text 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border-top:solid windo=
wtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Adakveo 5&nbsp;mg/kg (N=3D67)</span><=
/b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(standard
  median)<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border-top:solid window=
text 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Placebo (N=3D65)</span></b><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(standard
  median)<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border-top:solid window=
text 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Change vs placebo<o:p></o:p></span></=
b></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border-top:solid wind=
owtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Hodges&#8209;Lehmann
  median difference</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
  mso-bidi-font-weight:bold'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>(95%
  CI)</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D121 rowspan=3D2 style=3D'width:90.45pt;border:none;border-bot=
tom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>HU/HC
  use<o:p></o:p></span></p>
  </td>
  <td width=3D85 style=3D'width:63.8pt;border:none;mso-border-top-alt:solid=
 windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Yes<o:p></o:p></span></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border:none;mso-border=
-top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D42<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2.43<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;mso-border-=
top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D 40<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>3.58<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;mso-border-=
top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;32.1%<o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:none;mso-borde=
r-top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;1.01<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;2.44,
  0.00)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D85 style=3D'width:63.8pt;border:none;border-bottom:solid wind=
owtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>No<o:p></o:p></span></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border:none;border-bot=
tom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D25<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>1.00<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;border-bott=
om:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D25<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2.00<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;border-bott=
om:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;50.0%<o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;1.02<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;2.00,
  0.00)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid;height:20.2pt'>
  <td width=3D121 rowspan=3D2 style=3D'width:90.45pt;border:none;border-bot=
tom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:20.2pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Number
  of VOCs in previous 12&nbsp;months<o:p></o:p></span></p>
  </td>
  <td width=3D85 style=3D'width:63.8pt;border:none;mso-border-top-alt:solid=
 windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:20.2pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2&#8209;4&nbsp;VOCs<o:p></o:p></span></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border:none;mso-border=
-top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:20.2pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D42<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>1.14<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;mso-border-=
top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:20.2pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D41<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2.00<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;mso-border-=
top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:20.2pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;43.0%<o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:none;mso-borde=
r-top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:20.2pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;0.05<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;1.56,
  0.01)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D85 style=3D'width:63.8pt;border:none;border-bottom:solid wind=
owtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>5&#8209;10&nbsp;VOCs<o:p></o:p></span></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border:none;border-bot=
tom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D25<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>1.97<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;border-bott=
om:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D24<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>5.32<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;border-bott=
om:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;63.0%<o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;2.74<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;5.00,
  &#8209;0.83)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D121 rowspan=3D2 style=3D'width:90.45pt;border:none;border-bot=
tom:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Sickle
  cell disease genotypes, including HbSC<o:p></o:p></span></p>
  </td>
  <td width=3D85 style=3D'width:63.8pt;border:none;mso-border-top-alt:solid=
 windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>HbSS<o:p></o:p></span></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border:none;mso-border=
-top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D47<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>1.97<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;mso-border-=
top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D47<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>3.01<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;mso-border-=
top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;34.6%<o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:none;mso-borde=
r-top-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;1.01<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;2.18,
  0.00)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;mso-yfti-lastrow:yes;page-break-inside:avoid'>
  <td width=3D85 style=3D'width:63.8pt;border:none;border-bottom:solid wind=
owtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Non&#8209;HbSS<o:p></o:p></span></p>
  </td>
  <td width=3D94 valign=3Dtop style=3D'width:70.85pt;border:none;border-bot=
tom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D20<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>0.99<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;border-bott=
om:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>n=3D18<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>2.00<o:p></o:p></span></p>
  </td>
  <td width=3D85 valign=3Dtop style=3D'width:63.8pt;border:none;border-bott=
om:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;50.5%<o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>&#8209;1.01<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orp=
han lines-together;
  page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>(&#8209;2.01,
  0.00)<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>A
greater than two&#8209;fold increase in the proportion of patients with no =
VOC and
who completed the study was observed in the Adakveo 5&nbsp;mg/kg group comp=
ared
to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar
difference was also observed across important subgroups (HU/HC use, genotyp=
e).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Treatment
with Adakveo 5&nbsp;mg/kg was also associated with a three&#8209;fold longer
Kaplan&#8209;Meier estimated median time to first VOC compared with placebo=
 (4.07
vs 1.38&nbsp;months; HR=3D0.495, 95% CI: 0.331, 0.741) (Figure&nbsp;1) and =
a two&#8209;fold
longer median time from randomisation to second VOC compared to placebo (10=
.32
vs 5.09&nbsp;months; HR=3D0.534, 95% CI: 0.329, 0.866).<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Figure&nbsp;1<span
style=3D'mso-tab-count:1'> </span>Kaplan&#8209;Meier curve of time to =
first
VOC</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:widow-orphan lines-t=
ogether;
page-break-after:avoid'><v:rect id=3D"Rectangle_x0020_1232" o:spid=3D"_x000=
0_s1093"
 style=3D'position:absolute;left:0;text-align:left;margin-left:45.4pt;
 margin-top:158.3pt;width:9.75pt;height:7.05pt;z-index:251748352;visibility=
:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right=
:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dright style=3D'margin-top:0in;text-alig=
n:right;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>0<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1235" o:spid=3D"_x0000_s1092" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:47.4pt;margin-top:142.4pt;width:7.65pt;
 height:8.1pt;z-index:251746304;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>10<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1234" o:spid=3D"_x0000_s1091" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:47.55pt;margin-top:126.35pt;width:7.65p=
t;
 height:8.1pt;z-index:251744256;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>20<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1236" o:spid=3D"_x0000_s1090" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:47.55pt;margin-top:111.9pt;width:7.65pt;
 height:8.1pt;z-index:251742208;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>30<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1237" o:spid=3D"_x0000_s1089" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:48.3pt;margin-top:97.1pt;width:7.65pt;
 height:8.1pt;z-index:251740160;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>40<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1238" o:spid=3D"_x0000_s1088" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:48.05pt;margin-top:82pt;width:7.65pt;
 height:8.1pt;z-index:251738112;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>50<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1239" o:spid=3D"_x0000_s1087" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:47.7pt;margin-top:67.25pt;width:7.65pt;
 height:8.1pt;z-index:251736064;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>60<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1240" o:spid=3D"_x0000_s1086" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:48.2pt;margin-top:52.3pt;width:7.65pt;
 height:8.1pt;z-index:251734016;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>70<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1241" o:spid=3D"_x0000_s1085" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:47.5pt;margin-top:35.95pt;width:7.65pt;
 height:8.1pt;z-index:251731968;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQCn26Gk6wEAAMgDAAAOAAAAZHJzL2Uyb0RvYy54bWysU8Fu2zAMvQ/YPwi6L46DpmuNOMXQIsOA
riuWDj3TshwbkERNUmJnXz9KsdOtuxW7CBRJPfI9UqubQSt2kM53aEqez+acSSOw7syu5D+eNh+u
OPMBTA0KjSz5UXp+s37/btXbQi6wRVVLxwjE+KK3JW9DsEWWedFKDX6GVhoKNug0BLq6XVY76Ald
q2wxn19mPbraOhTSe/LenYJ8nfCbRorwrWm8DEyVnHoL6XTprOKZrVdQ7BzYthNjG/CGLjR0hoqe
oe4gANu77h8o3QmHHpswE6gzbJpOyMSB2OTzV2y2LViZuJA43p5l8v8PVjwcHh3raprd4iLnzICm
KX0n3cDslGTJSyL11heUu7WPbrx5MlnVf8WaHsA+YOI/NE5HHYgZG5LMx7PMcghMkPP6Y75cciYo
cn1xmS/jEDIopqfW+fBZombRKLmjXhI0HO59OKVOKbGSwU2nFPmhUOYvB2FGTxZ7j92eWIShGhLh
q1g3xiqsj8SFtpjKteh+cdbTRpTc/9yDk5ypL4Ykj+szGW4yqskwe32LtGSkIRhBKCUPk3kbThtH
I7cQ7s3WipgYm41MnoZncHakG0ilB5wmD8Ur1qfc+NLbTyT6pkuSvNAY+dK6JFHH1Y77+Oc9Zb18
wPVvAAAA//8DAFBLAwQUAAYACAAAACEAcdHhMd4AAAAIAQAADwAAAGRycy9kb3ducmV2LnhtbEyP
wU7DMBBE70j8g7VIXBB1UkSbhGwqhNQbEmrgUG5uvMSBeB3FbhP4etwTHEczmnlTbmbbixONvnOM
kC4SEMSN0x23CG+v29sMhA+KteodE8I3edhUlxelKrSbeEenOrQilrAvFIIJYSik9I0hq/zCDcTR
+3CjVSHKsZV6VFMst71cJslKWtVxXDBqoCdDzVd9tAjbl31H/CN3N3k2uc9m+V6b5wHx+mp+fAAR
aA5/YTjjR3SoItPBHVl70SPk9/FKQFinOYiznyZ3IA4I2SoDWZXy/4HqFwAA//8DAFBLAQItABQA
BgAIAAAAIQC2gziS/gAAAOEBAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1s
UEsBAi0AFAAGAAgAAAAhADj9If/WAAAAlAEAAAsAAAAAAAAAAAAAAAAALwEAAF9yZWxzLy5yZWxz
UEsBAi0AFAAGAAgAAAAhAKfboaTrAQAAyAMAAA4AAAAAAAAAAAAAAAAALgIAAGRycy9lMm9Eb2Mu
eG1sUEsBAi0AFAAGAAgAAAAhAHHR4THeAAAACAEAAA8AAAAAAAAAAAAAAAAARQQAAGRycy9kb3du
cmV2LnhtbFBLBQYAAAAABAAEAPMAAABQBQAAAAA=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>80<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1242" o:spid=3D"_x0000_s1084" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:48.4pt;margin-top:21.15pt;width:7.65pt;
 height:8.1pt;z-index:251729920;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQBRCean6wEAAMgDAAAOAAAAZHJzL2Uyb0RvYy54bWysU8Fu2zAMvQ/YPwi6L46DpluMOMXQIsOA
riuaDjvTshwbkERNUmJnXz9KsdOtuw27CBRJPfI9UuubQSt2lM53aEqez+acSSOw7sy+5N+et+8+
cOYDmBoUGlnyk/T8ZvP2zbq3hVxgi6qWjhGI8UVvS96GYIss86KVGvwMrTQUbNBpCHR1+6x20BO6
VtliPr/OenS1dSik9+S9Owf5JuE3jRTha9N4GZgqOfUW0unSWcUz26yh2DuwbSfGNuAfutDQGSp6
gbqDAOzgur+gdCccemzCTKDOsGk6IRMHYpPPX7HZtWBl4kLieHuRyf8/WPFwfHSsq2l2i6sFZwY0
TemJdAOzV5IlL4nUW19Q7s4+uvHmyWRV/wVregCHgIn/0DgddSBmbEgyny4yyyEwQc7V+3y55ExQ
ZHV1nS/jEDIopqfW+fBJombRKLmjXhI0HO99OKdOKbGSwW2nFPmhUOYPB2FGTxZ7j92eWYShGhLh
VawbYxXWJ+JCW0zlWnQ/OetpI0rufxzASc7UZ0OSx/WZDDcZ1WSYg75FWrKcMzCCUEoeJvM2nDeO
Rm4h3JudFTExNhuZPA/fwdmRbiCVHnCaPBSvWJ9z40tvP5Lo2y5J8kJj5EvrkkQdVzvu4+/3lPXy
ATe/AAAA//8DAFBLAwQUAAYACAAAACEALilzfN8AAAAIAQAADwAAAGRycy9kb3ducmV2LnhtbEyP
wU7DMBBE70j8g7VIXBB1EqC0IZsKIfWGhBo4tDc3XuJAvI5itwl8Pe6JHkczmnlTrCbbiSMNvnWM
kM4SEMS10y03CB/v69sFCB8Ua9U5JoQf8rAqLy8KlWs38oaOVWhELGGfKwQTQp9L6WtDVvmZ64mj
9+kGq0KUQyP1oMZYbjuZJclcWtVyXDCqpxdD9Xd1sAjrt21L/Cs3N8vF6L7qbFeZ1x7x+mp6fgIR
aAr/YTjhR3QoI9PeHVh70SEs55E8INxndyBOfpqlIPYID48ZyLKQ5wfKPwAAAP//AwBQSwECLQAU
AAYACAAAACEAtoM4kv4AAADhAQAAEwAAAAAAAAAAAAAAAAAAAAAAW0NvbnRlbnRfVHlwZXNdLnht
bFBLAQItABQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAAAAAAAAAAAAAAC8BAABfcmVscy8ucmVs
c1BLAQItABQABgAIAAAAIQBRCean6wEAAMgDAAAOAAAAAAAAAAAAAAAAAC4CAABkcnMvZTJvRG9j
LnhtbFBLAQItABQABgAIAAAAIQAuKXN83wAAAAgBAAAPAAAAAAAAAAAAAAAAAEUEAABkcnMvZG93
bnJldi54bWxQSwUGAAAAAAQABADzAAAAUQUAAAAA
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>90<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1233" o:spid=3D"_x0000_s1083" style=
=3D'position:absolute;
 left:0;text-align:left;margin-left:44.9pt;margin-top:6.9pt;width:11pt;
 height:8.1pt;z-index:251727872;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>100<o:p></o:p>=
</span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:group id=3D"Group_x0020_628" o:spid=3D"_x0000_s1075" style=3D'p=
osition:absolute;
 left:0;text-align:left;margin-left:343.95pt;margin-top:5.55pt;width:93.9pt;
 height:28.95pt;z-index:251781120' coordorigin=3D"8333,10912" coordsize=3D"=
1878,579"
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
">
 <v:rect id=3D"Rectangle_x0020_1352" o:spid=3D"_x0000_s1076" style=3D'posit=
ion:absolute;
  left:8333;top:10912;width:1878;height:566;visibility:visible;
  mso-wrap-style:square;v-text-anchor:middle' o:gfxdata=3D"UEsDBBQABgAIAAAA=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" stroked=3D"f" strokeweight=3D"1pt"/>
 <v:rect id=3D"Rectangle_x0020_1353" o:spid=3D"_x0000_s1077" style=3D'posit=
ion:absolute;
  left:8927;top:11085;width:1002;height:162;visibility:visible;
  mso-wrap-style:none;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAAAIQDb4=
fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled=3D"f" stroked=3D"f">
  <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
   <![if !mso]>
   <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=3DDedicatednumber style=3D'margin-top:0in;punctuation-wrap:si=
mple;
     mso-line-break-override:restrictions;vertical-align:baseline'><span
     style=3D'font-size:6.5pt;mso-bidi-font-size:10.0pt;color:black;mso-fon=
t-kerning:
     12.0pt;mso-bidi-font-weight:bold'>Adakveo 5&nbsp;mg/kg </span><span
     style=3D'font-size:6.5pt;mso-bidi-font-size:10.0pt'><o:p></o:p></span>=
</p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id=3D"Rectangle_x0020_1354" o:spid=3D"_x0000_s1078" style=
=3D'position:absolute;
  left:8927;top:11329;width:469;height:162;visibility:visible;mso-wrap-styl=
e:none;
  v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW=
0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=3D
" filled=3D"f" stroked=3D"f">
  <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
   <![if !mso]>
   <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=3DDedicatednumber style=3D'margin-top:0in;punctuation-wrap:si=
mple;
     mso-line-break-override:restrictions;vertical-align:baseline'><span
     style=3D'font-size:6.5pt;mso-bidi-font-size:7.5pt;color:black;mso-font=
-kerning:
     12.0pt'>Placebo</span><span style=3D'font-size:6.5pt;mso-bidi-font-siz=
e:
     7.5pt'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:line id=3D"Straight_x0020_Connector_x0020_1355" o:spid=3D"_x00=
00_s1079"
  style=3D'position:absolute;flip:x;visibility:visible;mso-wrap-style:squar=
e'
  from=3D"8495,11393" to=3D"8875,11393" o:connectortype=3D"straight" o:gfxd=
ata=3D"UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQ=
z07DMAyH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" strokeweight=3D".5pt">
  <v:stroke joinstyle=3D"miter"/>
 </v:line><v:line id=3D"Straight_x0020_Connector_x0020_1356" o:spid=3D"_x00=
00_s1080"
  style=3D'position:absolute;flip:x;visibility:visible;mso-wrap-style:squar=
e'
  from=3D"8495,11161" to=3D"8875,11161" o:connectortype=3D"straight" o:gfxd=
ata=3D"UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQ=
z07DMAyH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=3D=3D
" strokeweight=3D".5pt">
  <v:stroke joinstyle=3D"miter"/>
 </v:line><v:rect id=3D"Rectangle_x0020_1357" o:spid=3D"_x0000_s1081" style=
=3D'position:absolute;
  left:8631;top:11113;width:88;height:88;visibility:visible;mso-wrap-style:=
square;
  v-text-anchor:middle' o:gfxdata=3D"UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAA=
AAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=3D=3D
" filled=3D"f" strokeweight=3D"1pt"/>
 <v:oval id=3D"Oval_x0020_1358" o:spid=3D"_x0000_s1082" style=3D'position:a=
bsolute;
  left:8631;top:11345;width:96;height:96;visibility:visible;mso-wrap-style:=
square;
  v-text-anchor:middle' o:gfxdata=3D"UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAA=
AAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=3D=3D
" filled=3D"f" strokeweight=3D"1pt">
  <v:stroke joinstyle=3D"miter"/>
 </v:oval></v:group><v:rect id=3D"Rectangle_x0020_454" o:spid=3D"_x0000_s10=
74"
 style=3D'position:absolute;left:0;text-align:left;margin-left:370.7pt;
 margin-top:5pt;width:68.35pt;height:18.9pt;z-index:251779072;visibility:vi=
sible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right=
:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxd=
ata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSR=
QU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQBDdCDe+gEAAPADAAAOAAAAZHJzL2Uyb0RvYy54bWysU9uO0zAQfUfiHyy/06SlrUrUdIW6lJcF
VrvwAVPHSSx8Y+w2LV/P2L3sLrwgRB6ssWd8cubM8fLmYDTbSwzK2ZqPRyVn0grXKNvV/NvXzZsF
ZyGCbUA7K2t+lIHfrF6/Wg6+khPXO91IZARiQzX4mvcx+qooguilgTByXlpKtg4NRNpiVzQIA6Eb
XUzKcl4MDhuPTsgQ6PT2lOSrjN+2UsQvbRtkZLrmxC3mFfO6TWuxWkLVIfheiTMN+AcWBpSln16h
biEC26H6A8oogS64No6EM4VrWyVk7oG6GZe/dfPYg5e5FxIn+KtM4f/Bis/7e2SqodnNObNgaEYP
pBrYTks2nU2TQoMPFRU++ntMPQZ/58T3wKxb91Qn3yO6oZfQEK9xqi9eXEibQFfZdvjkGsKHXXRZ
rEOLJgGSDOyQZ3K8zkQeIhN0uJgvyumMM0GpybQs3+aZFVBdLnsM8aN0hqWg5kjkMzjs70JMZKC6
lGTyTqtmo7TOG+y2a41sD2SPTf4yf+rxeZm2bKj5u9lklpFf5MLfQRgVyedaGeqoTN/JeUm1D7bJ
Loyg9CkmytqeZUzKnSawdc2RVER3MjE9Ogp6hz85G8jANQ8/doCSM7CCjmseL+E6nhy/86i6nm49
TYlslSU6P4Hk2+f7TOLpoa5+AQAA//8DAFBLAwQUAAYACAAAACEAuG0FPt0AAAAJAQAADwAAAGRy
cy9kb3ducmV2LnhtbEyPwU7DMBBE70j8g7VI3KgTFJEojVNBCeLCoRS4b+1tEhHbUey2KV/PcqLH
1TzNvqlWsx3EkabQe6cgXSQgyGlvetcq+Px4uStAhIjO4OAdKThTgFV9fVVhafzJvdNxG1vBJS6U
qKCLcSylDLoji2HhR3Kc7f1kMfI5tdJMeOJyO8j7JHmQFnvHHzocad2R/t4erIIN4vPm51Xrp+b8
ljW0/mrID0rd3syPSxCR5vgPw58+q0PNTjt/cCaIQUGepRmjHCS8iYEiL1IQOwVZXoCsK3m5oP4F
AAD//wMAUEsBAi0AFAAGAAgAAAAhALaDOJL+AAAA4QEAABMAAAAAAAAAAAAAAAAAAAAAAFtDb250
ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEAOP0h/9YAAACUAQAACwAAAAAAAAAAAAAAAAAv
AQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEAQ3Qg3voBAADwAwAADgAAAAAAAAAAAAAAAAAu
AgAAZHJzL2Uyb0RvYy54bWxQSwECLQAUAAYACAAAACEAuG0FPt0AAAAJAQAADwAAAAAAAAAAAAAA
AABUBAAAZHJzL2Rvd25yZXYueG1sUEsFBgAAAAAEAAQA8wAAAF4FAAAAAA=3D=3D
" strokecolor=3D"white"/><v:rect id=3D"Rectangle_x0020_1268" o:spid=3D"_x00=
00_s1073"
 style=3D'position:absolute;left:0;text-align:left;margin-left:-38.25pt;
 margin-top:75.25pt;width:133.85pt;height:24.1pt;rotation:-90;z-index:25166=
6432;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'layout-flow:vertical;mso-layout-flow-alt:bottom-to-top'
  inset=3D"0,0,0,0">
  <!--[if RotText]><![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:8.0pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>Probabil=
ity
    of being free from first VOC (%)</span><span style=3D'font-size:8.0pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]><![endif]--></v:textbox>
</v:rect><![if !vml]><span style=3D'mso-ignore:vglayout;position:absolute;
z-index:251666432;left:0px;margin-left:22px;margin-top:27px;width:36px;
height:183px'><![endif]><![if !RotText]><img width=3D36 height=3D183
src=3D"Adakveo_clean_files/image002.png"
alt=3D"Text Box: Probability of being free from first VOC (%)" v:shapes=3D"=
Rectangle_x0020_1268"
class=3Dshape v:dpi=3D"96"><![endif]><![if !vml]></span><![endif]><v:rect i=
d=3D"Rectangle_x0020_1311"
 o:spid=3D"_x0000_s1072" style=3D'position:absolute;left:0;text-align:left;
 margin-left:239.85pt;margin-top:181.6pt;width:41.75pt;height:8.1pt;z-index=
:251725824;
 visibility:visible;mso-wrap-style:none;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAAAI=
QC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;mso-bidi-font-size:10.0pt;
    font-family:"Arial",sans-serif;color:black;mso-font-kerning:12.0pt;
    mso-bidi-font-weight:bold'>Time (months)</span><span style=3D'font-=
size:
    6.5pt;mso-bidi-font-size:10.0pt;font-family:"Arial",sans-serif;color:bl=
ack'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><sub><span style=3D'font-size:11.0pt;mso-fareast-language:EN-US;
mso-no-proof:yes'><span
style=3D'mso-spacerun:yes'> </span><v:shape =
id=3D"Picture_x0020_1243"
 o:spid=3D"_x0000_i1026" type=3D"#_x0000_t75" style=3D'width:388.5pt;height=
:167.25pt;
 visibility:visible;mso-wrap-style:square'>
 <v:imagedata src=3D"Adakveo_clean_files/image003.png" o:title=3D"" cropbot=
tom=3D"17136f"
  cropleft=3D"9449f" grayscale=3D"t"/>
</v:shape></span></sub><span style=3D'font-size:11.0pt'><o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt'><v:rect id=3D"Rectangle_x0020_126=
7"
 o:spid=3D"_x0000_s1057" style=3D'position:absolute;margin-left:70.3pt;
 margin-top:18.4pt;width:74pt;height:7.75pt;z-index:251664384;visibility:vi=
sible;
 mso-wrap-style:none;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right=
:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxd=
ata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSR=
QU7DMBBF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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><b><span
    style=3D'font-size:6.0pt;font-family:"Arial",sans-serif;color:black;
    mso-font-kerning:12.0pt'>Number of patients at risk</span></b><b
    style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:6.0pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></b></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1231" o:spid=3D"_x0000_s1058" style=
=3D'position:absolute;
 margin-left:60.35pt;margin-top:.2pt;width:7.65pt;height:8.1pt;z-index:2517=
50400;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>0<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1229" o:spid=3D"_x0000_s1060" style=
=3D'position:absolute;
 margin-left:115.7pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
754496;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>2<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1227" o:spid=3D"_x0000_s1062" style=
=3D'position:absolute;
 margin-left:170.9pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
758592;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>4<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1225" o:spid=3D"_x0000_s1064" style=
=3D'position:absolute;
 margin-left:225.7pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
762688;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>6<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1223" o:spid=3D"_x0000_s1066" style=
=3D'position:absolute;
 margin-left:281.85pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:25=
1766784;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>8<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1221" o:spid=3D"_x0000_s1068" style=
=3D'position:absolute;
 margin-left:338.75pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:25=
1770880;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>10<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1219" o:spid=3D"_x0000_s1070" style=
=3D'position:absolute;
 margin-left:392.7pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
774976;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>12<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1218" o:spid=3D"_x0000_s1071" style=
=3D'position:absolute;
 margin-left:420.6pt;margin-top:.65pt;width:7.65pt;height:8.1pt;z-index:251=
777024;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>13<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1220" o:spid=3D"_x0000_s1069" style=
=3D'position:absolute;
 margin-left:365.65pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:25=
1772928;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>11<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1222" o:spid=3D"_x0000_s1067" style=
=3D'position:absolute;
 margin-left:309.15pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:25=
1768832;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>9<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1224" o:spid=3D"_x0000_s1065" style=
=3D'position:absolute;
 margin-left:252.7pt;margin-top:.25pt;width:9.8pt;height:8.1pt;flip:x;
 z-index:251764736;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>7<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1226" o:spid=3D"_x0000_s1063" style=
=3D'position:absolute;
 margin-left:199.1pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
760640;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>5<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1228" o:spid=3D"_x0000_s1061" style=
=3D'position:absolute;
 margin-left:142.1pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
756544;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>3<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1230" o:spid=3D"_x0000_s1059" style=
=3D'position:absolute;
 margin-left:87.85pt;margin-top:.25pt;width:7.65pt;height:8.1pt;z-index:251=
752448;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif=
'>1<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_21" o:spid=3D"_x0000_s1042" style=3D=
'position:absolute;
 margin-left:56.85pt;margin-top:30.4pt;width:383.95pt;height:31.2pt;z-index=
:251658240;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:middle' o:gfxdata=3D"UEsDBBQABgAI=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=3D=3D
" filled=3D"f" strokecolor=3D"windowText" strokeweight=3D".25pt"/><v:rect i=
d=3D"Rectangle_x0020_1264"
 o:spid=3D"_x0000_s1041" style=3D'position:absolute;margin-left:1.85pt;
 margin-top:36.05pt;width:53.3pt;height:8.3pt;z-index:251660288;visibility:=
visible;
 mso-wrap-style:none;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right=
:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxd=
ata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSR=
QU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><b><span
    style=3D'font-size:6.5pt;mso-bidi-font-size:10.0pt;font-family:"Arial",=
sans-serif;
    color:black;mso-font-kerning:12.0pt'>Adakveo 5 mg/kg </span></b><b
    style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:6.5pt;
    mso-bidi-font-size:10.0pt;font-family:"Arial",sans-serif'><o:p></o:p></=
span></b></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1265" o:spid=3D"_x0000_s1026" style=
=3D'position:absolute;
 margin-left:29.4pt;margin-top:53.85pt;width:24.85pt;height:8.3pt;z-index:2=
51662336;
 visibility:visible;mso-wrap-style:none;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAAAI=
QC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><b
    style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:6.5pt;
    mso-bidi-font-size:7.5pt;font-family:"Arial",sans-serif;color:black;
    mso-font-kerning:12.0pt'>Placebo</span></b><b style=3D'mso-bidi-font-we=
ight:
    normal'><span style=3D'font-size:6.5pt;mso-bidi-font-size:7.5pt;font-fa=
mily:
    "Arial",sans-serif'><o:p></o:p></span></b></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1269" o:spid=3D"_x0000_s1049" style=
=3D'position:absolute;
 margin-left:60.75pt;margin-top:34.6pt;width:7.65pt;height:8.1pt;z-index:25=
1668480;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText style=3D'margin-top:0in;punctuation-wrap:simple;
    mso-line-break-override:restrictions;vertical-align:baseline'><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'>67<o:p></o:p><=
/span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1270" o:spid=3D"_x0000_s1043" style=
=3D'position:absolute;
 margin-left:86.85pt;margin-top:34.1pt;width:8.4pt;height:8.1pt;z-index:251=
670528;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>49</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1271" o:spid=3D"_x0000_s1048" style=
=3D'position:absolute;
 margin-left:112.75pt;margin-top:34.5pt;width:14pt;height:6.8pt;z-index:251=
672576;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>41</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1272" o:spid=3D"_x0000_s1047" style=
=3D'position:absolute;
 margin-left:139.35pt;margin-top:34.4pt;width:14pt;height:8.1pt;z-index:251=
674624;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>35</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1273" o:spid=3D"_x0000_s1050" style=
=3D'position:absolute;
 margin-left:164.95pt;margin-top:33.75pt;width:16.35pt;height:8.1pt;z-index=
:251676672;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>30</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1274" o:spid=3D"_x0000_s1051" style=
=3D'position:absolute;
 margin-left:195.6pt;margin-top:34pt;width:12.9pt;height:8.1pt;z-index:2516=
78720;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>26</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1275" o:spid=3D"_x0000_s1052" style=
=3D'position:absolute;
 margin-left:222.5pt;margin-top:34.1pt;width:15.65pt;height:8.1pt;z-index:2=
51680768;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>24</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1276" o:spid=3D"_x0000_s1054" style=
=3D'position:absolute;
 margin-left:249.8pt;margin-top:33.75pt;width:14.75pt;height:8.1pt;z-index:=
251682816;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>20</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1277" o:spid=3D"_x0000_s1053" style=
=3D'position:absolute;
 margin-left:278.25pt;margin-top:33.5pt;width:14.3pt;height:8.1pt;z-index:2=
51684864;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=
AIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQDBfhVk7QEAAMoDAAAOAAAAZHJzL2Uyb0RvYy54bWysU8Fu2zAMvQ/YPwi6L47TLW2NOMXQIsOA
riuWDjvTshwLsERNUmJnXz9KsdO1uw27CBRJPfI9UqubQXfsIJ1XaEqez+acSSOwVmZX8u9Pm3dX
nPkApoYOjSz5UXp+s377ZtXbQi6wxa6WjhGI8UVvS96GYIss86KVGvwMrTQUbNBpCHR1u6x20BO6
7rLFfL7MenS1dSik9+S9OwX5OuE3jRTha9N4GVhXcuotpNOls4pntl5BsXNgWyXGNuAfutCgDBU9
Q91BALZ36i8orYRDj02YCdQZNo0SMnEgNvn8FZttC1YmLiSOt2eZ/P+DFQ+HR8dUTbNbXF5yZkDT
lL6RbmB2nWTJSyL11heUu7WPbrx5MlnVf8GaHsA+YOI/NE5HHYgZG5LMx7PMcghMkDO/ypc5DUNQ
6Pr9Mv8Qp5BBMb21zodPEjWLRskdNZOw4XDvwyl1SomlDG5U15Efis68cBBm9GSx+djuiUYYqiEx
vriIhWOwwvpIbGiPqV6L7hdnPe1Eyf3PPTjJWffZkOhxgSbDTUY1GWavb5HWLOcMjCCUkofJvA2n
naOhWwj3ZmtFTIzdRipPww9wduQbSKcHnGYPxSvap9z40tuPJPtGJU2eaYyEaWGSquNyx438856y
nr/g+jcAAAD//wMAUEsDBBQABgAIAAAAIQDWIQzz3wAAAAkBAAAPAAAAZHJzL2Rvd25yZXYueG1s
TI/BTsMwEETvSPyDtUhcEHUamioNcSqE1BsSauAANzde4kC8jmK3CXw9y6kcV/M087bczq4XJxxD
50nBcpGAQGq86ahV8Pqyu81BhKjJ6N4TKvjGANvq8qLUhfET7fFUx1ZwCYVCK7AxDoWUobHodFj4
AYmzDz86HfkcW2lGPXG562WaJGvpdEe8YPWAjxabr/roFOye3zqkH7m/2eST/2zS99o+DUpdX80P
9yAizvEMw58+q0PFTgd/JBNEryDL1hmjHKxWIBjI8mwJ4qAg3dyBrEr5/4PqFwAA//8DAFBLAQIt
ABQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10u
eG1sUEsBAi0AFAAGAAgAAAAhADj9If/WAAAAlAEAAAsAAAAAAAAAAAAAAAAALwEAAF9yZWxzLy5y
ZWxzUEsBAi0AFAAGAAgAAAAhAMF+FWTtAQAAygMAAA4AAAAAAAAAAAAAAAAALgIAAGRycy9lMm9E
b2MueG1sUEsBAi0AFAAGAAgAAAAhANYhDPPfAAAACQEAAA8AAAAAAAAAAAAAAAAARwQAAGRycy9k
b3ducmV2LnhtbFBLBQYAAAAABAAEAPMAAABTBQAAAAA=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>18</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1278" o:spid=3D"_x0000_s1044" style=
=3D'position:absolute;
 margin-left:306.1pt;margin-top:33.55pt;width:14.3pt;height:8.1pt;z-index:2=
51686912;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=
AIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQBikK8J7AEAAMoDAAAOAAAAZHJzL2Uyb0RvYy54bWysU1Fv0zAQfkfiP1h+p2mqUUbUdEKbipDG
mOgQzxfHaSzFPmO7Tcqv5+wkHYw3xIt1vjt/d993583NoDt2ks4rNCXPF0vOpBFYK3Mo+ben3Ztr
znwAU0OHRpb8LD2/2b5+teltIVfYYldLxwjE+KK3JW9DsEWWedFKDX6BVhoKNug0BLq6Q1Y76Ald
d9lquVxnPbraOhTSe/LejUG+TfhNI0X40jReBtaVnHoL6XTprOKZbTdQHBzYVompDfiHLjQoQ0Uv
UHcQgB2d+gtKK+HQYxMWAnWGTaOETByITb58wWbfgpWJC4nj7UUm//9gxcPp0TFV0+xW72hWBjRN
6SvpBubQSZa8JFJvfUG5e/voppsnk1X9Z6zpARwDJv5D43TUgZixIcl8vsgsh8AEOfPrfJ3TMASF
3l+t87dxChkU81vrfPgoUbNolNxRMwkbTvc+jKlzSixlcKe6jvxQdOYPB2FGTxabj+2ONMJQDYnx
1SoWjsEK6zOxoT2mei26n5z1tBMl9z+O4CRn3SdDoscFmg03G9VsmKO+RVqznDMwglBKHmbzNow7
R0O3EO7N3oqYGLuNVJ6G7+DsxDeQTg84zx6KF7TH3PjS2w8k+04lTZ5pTIRpYZKq03LHjfz9nrKe
v+D2FwAAAP//AwBQSwMEFAAGAAgAAAAhAL5P8pDfAAAACQEAAA8AAABkcnMvZG93bnJldi54bWxM
j0FLw0AQhe+C/2EZwYvYTUMMbZpNEaE3QZp60Ns2O81Gs7Mhu22iv97xpMfhfbz5XrmdXS8uOIbO
k4LlIgGB1HjTUavg9bC7X4EIUZPRvSdU8IUBttX1VakL4yfa46WOreASCoVWYGMcCilDY9HpsPAD
EmcnPzod+RxbaUY9cbnrZZokuXS6I/5g9YBPFpvP+uwU7F7eOqRvub9bryb/0aTvtX0elLq9mR83
ICLO8Q+GX31Wh4qdjv5MJoheQb5MU0Y5yB5AMJBnCW85KkjXGciqlP8XVD8AAAD//wMAUEsBAi0A
FAAGAAgAAAAhALaDOJL+AAAA4QEAABMAAAAAAAAAAAAAAAAAAAAAAFtDb250ZW50X1R5cGVzXS54
bWxQSwECLQAUAAYACAAAACEAOP0h/9YAAACUAQAACwAAAAAAAAAAAAAAAAAvAQAAX3JlbHMvLnJl
bHNQSwECLQAUAAYACAAAACEAYpCvCewBAADKAwAADgAAAAAAAAAAAAAAAAAuAgAAZHJzL2Uyb0Rv
Yy54bWxQSwECLQAUAAYACAAAACEAvk/ykN8AAAAJAQAADwAAAAAAAAAAAAAAAABGBAAAZHJzL2Rv
d25yZXYueG1sUEsFBgAAAAAEAAQA8wAAAFIFAAAAAA=3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>17</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1279" o:spid=3D"_x0000_s1045" style=
=3D'position:absolute;
 margin-left:335.45pt;margin-top:34.1pt;width:14.1pt;height:8.1pt;z-index:2=
51688960;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>16</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1280" o:spid=3D"_x0000_s1056" style=
=3D'position:absolute;
 margin-left:363pt;margin-top:34.15pt;width:15.35pt;height:8.1pt;z-index:25=
1691008;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>15</span=
><span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1281" o:spid=3D"_x0000_s1046" style=
=3D'position:absolute;
 margin-left:390.75pt;margin-top:34.75pt;width:15.8pt;height:8.1pt;z-index:=
251693056;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>7</span>=
<span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1282" o:spid=3D"_x0000_s1027" style=
=3D'position:absolute;
 margin-left:58.35pt;margin-top:53.15pt;width:12.4pt;height:6.4pt;z-index:2=
51695104;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D
" filled=3D"f" stroked=3D"f">
 <v:textbox inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>65</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1283" o:spid=3D"_x0000_s1028" style=
=3D'position:absolute;
 margin-left:79.1pt;margin-top:52.95pt;width:25.2pt;height:8.1pt;z-index:25=
1697152;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>37</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1284" o:spid=3D"_x0000_s1029" style=
=3D'position:absolute;
 margin-left:110.45pt;margin-top:52.95pt;width:21.6pt;height:8.1pt;z-index:=
251699200;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=
AIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQBrl2267QEAAMoDAAAOAAAAZHJzL2Uyb0RvYy54bWysU1Fv0zAQfkfiP1h+p2lDV0bUdEKbipDG
mOgQzxfHaSzFPmO7Tcqv5+wmHYw3xIt1vjt/d9935/XNoDt2lM4rNCVfzOacSSOwVmZf8m9P2zfX
nPkApoYOjSz5SXp+s3n9at3bQubYYldLxwjE+KK3JW9DsEWWedFKDX6GVhoKNug0BLq6fVY76Ald
d1k+n6+yHl1tHQrpPXnvzkG+SfhNI0X40jReBtaVnHoL6XTprOKZbdZQ7B3YVomxDfiHLjQoQ0Uv
UHcQgB2c+gtKK+HQYxNmAnWGTaOETByIzWL+gs2uBSsTFxLH24tM/v/Biofjo2Oqptnl10vODGia
0lfSDcy+kyx5SaTe+oJyd/bRjTdPJqv6z1jTAzgETPyHxumoAzFjQ5L5dJFZDoEJcubvlm9zGoag
0PvlanEVp5BBMb21zoePEjWLRskdNZOw4Xjvwzl1SomlDG5V15Efis784SDM6Mli87HdM40wVENi
fLWKhWOwwvpEbGiPqV6L7idnPe1Eyf2PAzjJWffJkOhxgSbDTUY1Geagb5HWbMEZGEEoJQ+TeRvO
O0dDtxDuzc6KmBi7jVSehu/g7Mg3kE4POM0eihe0z7nxpbcfSPatSpo80xgJ08IkVcfljhv5+z1l
PX/BzS8AAAD//wMAUEsDBBQABgAIAAAAIQDw0IzQ3AAAAAcBAAAPAAAAZHJzL2Rvd25yZXYueG1s
TI7BTsMwEETvSPyDtUhcEHVqQWhDnAoh9YaEGjjAzY2XOBCvo9htAl/PcirH0TzNvHIz+14ccYxd
IA3LRQYCqQm2o1bD68v2egUiJkPW9IFQwzdG2FTnZ6UpbJhoh8c6tYJHKBZGg0tpKKSMjUNv4iIM
SNx9hNGbxHFspR3NxOO+lyrLculNR/zgzICPDpuv+uA1bJ/fOqQfubtar6bw2aj32j0NWl9ezA/3
IBLO6QTDnz6rQ8VO+3AgG0WvQalszaiGOxBcq/xmCWLP3G0Osirlf//qFwAA//8DAFBLAQItABQA
BgAIAAAAIQC2gziS/gAAAOEBAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1s
UEsBAi0AFAAGAAgAAAAhADj9If/WAAAAlAEAAAsAAAAAAAAAAAAAAAAALwEAAF9yZWxzLy5yZWxz
UEsBAi0AFAAGAAgAAAAhAGuXbbrtAQAAygMAAA4AAAAAAAAAAAAAAAAALgIAAGRycy9lMm9Eb2Mu
eG1sUEsBAi0AFAAGAAgAAAAhAPDQjNDcAAAABwEAAA8AAAAAAAAAAAAAAAAARwQAAGRycy9kb3du
cmV2LnhtbFBLBQYAAAAABAAEAPMAAABQBQAAAAA=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>23</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1285" o:spid=3D"_x0000_s1030" style=
=3D'position:absolute;
 margin-left:136.55pt;margin-top:52.95pt;width:21.45pt;height:8.1pt;z-index=
:251701248;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>21</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1286" o:spid=3D"_x0000_s1031" style=
=3D'position:absolute;
 margin-left:162.35pt;margin-top:52.9pt;width:22.7pt;height:8.1pt;z-index:2=
51703296;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=
AIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQCGT3jV7AEAAMoDAAAOAAAAZHJzL2Uyb0RvYy54bWysU8Fu2zAMvQ/YPwi6L06MNkiNOMXQIsOA
riuaDjvTshwLsERNUmJnXz9KjtOtuw27CBRJPfI9UuvbQXfsKJ1XaEq+mM05k0Zgrcy+5N9eth9W
nPkApoYOjSz5SXp+u3n/bt3bQubYYldLxwjE+KK3JW9DsEWWedFKDX6GVhoKNug0BLq6fVY76Ald
d1k+ny+zHl1tHQrpPXnvxyDfJPymkSJ8bRovA+tKTr2FdLp0VvHMNmso9g5sq8S5DfiHLjQoQ0Uv
UPcQgB2c+gtKK+HQYxNmAnWGTaOETByIzWL+hs2uBSsTFxLH24tM/v/Bisfjk2OqptnlqyVnBjRN
6Zl0A7PvJEteEqm3vqDcnX1y55snk1X9F6zpARwCJv5D43TUgZixIcl8usgsh8AEOfPVKr+hYQgK
3VwtF9dxChkU01vrfPgkUbNolNxRMwkbjg8+jKlTSixlcKu6jvxQdOYPB2FGTxabj+2ONMJQDYnx
9VUsHIMV1idiQ3tM9Vp0PznraSdK7n8cwEnOus+GRI8LNBluMqrJMAd9h7RmC87ACEIpeZjMuzDu
HA3dQngwOytiYuw2UnkZvoOzZ76BdHrEafZQvKE95saX3n4k2bcqafJK40yYFiapel7uuJG/31PW
6xfc/AIAAP//AwBQSwMEFAAGAAgAAAAhACSbXqLeAAAABwEAAA8AAABkcnMvZG93bnJldi54bWxM
jk1PwzAQRO9I/Q/WVuKCqNOUfhDiVAipNyTUlAPc3HiJA/E6it0m8OtZTvQ4mqeZl29H14oz9qHx
pGA+S0AgVd40VCt4PexuNyBC1GR06wkVfGOAbTG5ynVm/EB7PJexFjxCIdMKbIxdJmWoLDodZr5D
4u7D905Hjn0tTa8HHnetTJNkJZ1uiB+s7vDJYvVVnpyC3ctbg/Qj9zf3m8F/Vul7aZ87pa6n4+MD
iIhj/IfhT5/VoWCnoz+RCaJVsEjv1owqWIHgerFO5iCOzC2XIItcXvoXvwAAAP//AwBQSwECLQAU
AAYACAAAACEAtoM4kv4AAADhAQAAEwAAAAAAAAAAAAAAAAAAAAAAW0NvbnRlbnRfVHlwZXNdLnht
bFBLAQItABQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAAAAAAAAAAAAAAC8BAABfcmVscy8ucmVs
c1BLAQItABQABgAIAAAAIQCGT3jV7AEAAMoDAAAOAAAAAAAAAAAAAAAAAC4CAABkcnMvZTJvRG9j
LnhtbFBLAQItABQABgAIAAAAIQAkm16i3gAAAAcBAAAPAAAAAAAAAAAAAAAAAEYEAABkcnMvZG93
bnJldi54bWxQSwUGAAAAAAQABADzAAAAUQUAAAAA
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>17</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1287" o:spid=3D"_x0000_s1032" style=
=3D'position:absolute;
 margin-left:192.7pt;margin-top:52.95pt;width:18.1pt;height:8.1pt;z-index:2=
51705344;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>13</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1288" o:spid=3D"_x0000_s1033" style=
=3D'position:absolute;
 margin-left:220.75pt;margin-top:52.9pt;width:19.05pt;height:8.1pt;z-index:=
251707392;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>12</span><span style=3D'font-size:=
6.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1289" o:spid=3D"_x0000_s1034" style=
=3D'position:absolute;
 margin-left:249.8pt;margin-top:53pt;width:18.55pt;height:8.1pt;z-index:251=
709440;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>9</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1290" o:spid=3D"_x0000_s1035" style=
=3D'position:absolute;
 margin-left:279.15pt;margin-top:52.9pt;width:15.95pt;height:8.1pt;z-index:=
251711488;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=
AIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF
90jcwfIWJU67QAgl6YK0S0CoHGBkTxKLZGx5TGhvj5O2G0SRWNoz/78nu9wcxkFMGNg6quQqL6RA
0s5Y6ir5vt9lD1JwBDIwOMJKHpHlpr69KfdHjyxSmriSfYz+USnWPY7AufNIadK6MEJMx9ApD/oD
OlTrorhX2lFEilmcO2RdNtjC5xDF9pCuTyYBB5bi6bQ4syoJ3g9WQ0ymaiLzg5KdCXlKLjvcW893
SUOqXwnz5DrgnHtJTxOsQfEKIT7DmDSUCaxw7Rqn8787ZsmRM9e2VmPeBN4uqYvTtW7jvijg9N/y
JsXecLq0q+WD6m8AAAD//wMAUEsDBBQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAX3JlbHMvLnJl
bHOkkMFqwzAMhu+DvYPRfXGawxijTi+j0GvpHsDYimMaW0Yy2fr2M4PBMnrbUb/Q94l/f/hMi1qR
JVI2sOt6UJgd+ZiDgffL8ekFlFSbvV0oo4EbChzGx4f9GRdb25HMsYhqlCwG5lrLq9biZkxWOiqY
22YiTra2kYMu1l1tQD30/bPm3wwYN0x18gb45AdQl1tp5j/sFB2T0FQ7R0nTNEV3j6o9feQzro1i
OWA14Fm+Q8a1a8+Bvu/d/dMb2JY5uiPbhG/ktn4cqGU/er3pcvwCAAD//wMAUEsDBBQABgAIAAAA
IQAHyFHe6wEAAMoDAAAOAAAAZHJzL2Uyb0RvYy54bWysU8Fu2zAMvQ/YPwi6L3aMJViNOMXQIsOA
riuaDj3TshwbsERNUmJnXz9KttOtuxW7CBRFPfE9Pm2uB9Wxk7SuRV3w5SLlTGqBVasPBf/xtPvw
iTPnQVfQoZYFP0vHr7fv3216k8sMG+wqaRmBaJf3puCN9yZPEicaqcAt0EhNhzVaBZ629pBUFnpC
V12Spek66dFWxqKQzlH2djzk24hf11L473XtpGddwak3H1cb1zKsyXYD+cGCaVoxtQFv6EJBq+nR
C9QteGBH2/4DpVph0WHtFwJVgnXdChk5EJtl+orNvgEjIxcSx5mLTO7/wYr704NlbUWzy65IIA2K
pvRIuoE+dJLFLInUG5dT7d482GnnKGRl/w0rugBHj5H/UFsVdCBmbIgyny8yy8EzQckszVbrFWeC
jq4+rperMIUE8vmusc5/kahYCApuqZmIDac758fSuSQ8pXHXdh3lIe/0XwnCDJkkNB/aHWn4oRwi
41UcfzgssToTG/Ixvdeg/cVZT54ouPt5BCs5675qEj0YaA7sHJRzoI/qBslmS85AC0IpuJ/DGz96
joZuwN/pvRGhMHQbqDwNz2DNxNeTTvc4zx7yV7TH2nDTmc8k+66NmrzQmAiTYaKqk7mDI//cx6qX
L7j9DQAA//8DAFBLAwQUAAYACAAAACEAJcQ8ddwAAAAHAQAADwAAAGRycy9kb3ducmV2LnhtbEyO
wUrEMBRF94L/EJ7gRpzUSoZObTqIMDtBprrQXaZ5NtXmpTSZafXrfa50ebmHe0+1XfwgTjjFPpCG
m1UGAqkNtqdOw8vz7roAEZMha4ZAqOELI2zr87PKlDbMtMdTkzrBIxRLo8GlNJZSxtahN3EVRiTu
3sPkTeI4ddJOZuZxP8g8y9bSm574wZkRHxy2n83Ra9g9vfZI33J/tSnm8NHmb417HLW+vFju70Ak
XNIfDL/6rA41Ox3CkWwUgwaliltGNaxBcK02WQ7iwJxSIOtK/vevfwAAAP//AwBQSwECLQAUAAYA
CAAAACEAtoM4kv4AAADhAQAAEwAAAAAAAAAAAAAAAAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBL
AQItABQABgAIAAAAIQA4/SH/1gAAAJQBAAALAAAAAAAAAAAAAAAAAC8BAABfcmVscy8ucmVsc1BL
AQItABQABgAIAAAAIQAHyFHe6wEAAMoDAAAOAAAAAAAAAAAAAAAAAC4CAABkcnMvZTJvRG9jLnht
bFBLAQItABQABgAIAAAAIQAlxDx13AAAAAcBAAAPAAAAAAAAAAAAAAAAAEUEAABkcnMvZG93bnJl
di54bWxQSwUGAAAAAAQABADzAAAATgUAAAAA
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>8</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1291" o:spid=3D"_x0000_s1036" style=
=3D'position:absolute;
 margin-left:306.9pt;margin-top:52.9pt;width:15.25pt;height:8.1pt;z-index:2=
51713536;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>6</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1292" o:spid=3D"_x0000_s1037" style=
=3D'position:absolute;
 margin-left:337.95pt;margin-top:52.9pt;width:14.1pt;height:8.1pt;z-index:2=
51715584;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>5</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1293" o:spid=3D"_x0000_s1038" style=
=3D'position:absolute;
 margin-left:368pt;margin-top:53.05pt;width:8.4pt;height:8.1pt;z-index:2517=
17632;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>4</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1294" o:spid=3D"_x0000_s1039" style=
=3D'position:absolute;
 margin-left:392.55pt;margin-top:53.05pt;width:13.35pt;height:8.1pt;flip:x;
 z-index:251719680;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent=
:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata=3D"UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdL=
nhtbJSRQU7DMBBF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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>1</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1308" o:spid=3D"_x0000_s1055" style=
=3D'position:absolute;
 margin-left:418.4pt;margin-top:34.1pt;width:14.9pt;height:8.1pt;z-index:25=
1721728;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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3D=3D
" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold'>0</span>=
<span
    style=3D'font-size:6.5pt;font-family:"Arial",sans-serif'><o:p></o:p></s=
pan></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><v:rect id=3D"Rectangle_x0020_1309" o:spid=3D"_x0000_s1040" style=
=3D'position:absolute;
 margin-left:424pt;margin-top:52.85pt;width:3.6pt;height:8.1pt;z-index:2517=
23776;
 visibility:visible;mso-wrap-style:none;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata=3D"UEsDBBQABgAIAAA=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" filled=3D"f" stroked=3D"f">
 <v:textbox style=3D'mso-fit-shape-to-text:t' inset=3D"0,0,0,0">
  <![if !mso]>
  <table cellpadding=3D0 cellspacing=3D0 width=3D"100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=3DMsoPlainText align=3Dcenter style=3D'margin-top:0in;text-ali=
gn:center;
    punctuation-wrap:simple;mso-line-break-override:restrictions;vertical-a=
lign:
    baseline'><span style=3D'font-size:6.5pt;font-family:"Arial",sans-serif;
    color:black;mso-font-kerning:12.0pt'>0</span><span style=3D'font-size:6=
.5pt;
    font-family:"Arial",sans-serif'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:rect><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:widow-orphan lines-t=
ogether;
page-break-after:avoid'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:widow-orphan lines-t=
ogether;
page-break-after:avoid'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt;mso-layout-grid-align:none;text-au=
tospace:
none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<br style=3D'mso-ignore:vglayout' clear=3DALL>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><a name=3D"_hd6_Table_2_1_Patients_wit18544"></a><u><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-=
style:
italic'>Paediatric population</span></u><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-weight:
bold;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>The efficac=
y of
crizanlizumab in patients aged 16 and 17&nbsp;years is expected to be the s=
ame
as in adults. Three patients (2.7%) aged less than 18&nbsp;years were treat=
ed
with crizanlizumab 5&nbsp;mg/kg in clinical studies.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;mso-ou=
tline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>The
European Medicines Agency has deferred the obligation to submit the results=
 of
studies with <span style=3D'mso-bidi-font-style:italic;mso-no-proof:yes'>Ad=
akveo</span>
in one or more subsets of the paediatric population in the treatment of sic=
kle
cell disease (see section&nbsp;4.2 for information on paediatric use).<span
style=3D'mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;mso-ou=
tline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid;mso-list:skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;mso-bidi-font-style:italic;mso-no-proof:yes'>Conditional approval</s=
pan></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid;mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;mso-li=
st:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'>This medicinal product has been
authorised under a so&#8209;called conditional approval scheme. This means
that further evidence on this medicinal product is awaited.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;mso-li=
st:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic;mso-no-proof:yes'>The European Medicines Agency will review new
information on this medicinal product at least every year and this SmPC wil=
l be
updated as necessary.</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-bidi-font-st=
yle:
italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>5.2<span style=3D'mso-tab-count:1'> </span>Pha=
rmacokinetic
properties</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>Absorption</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>The median time to reach m=
aximum
serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92&nbsp;hours =
at
steady state following intravenous administration of 5&nbsp;mg/kg over a pe=
riod
of 30&nbsp;minutes in sickle cell disease patients.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>Distribution</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Crizanlizumab distribution=
 is
typical of endogenous human antibodies within the vascular and extracellular
spaces. The volume of distribution (V<sub>z</sub>) was 4.26&nbsp;litres aft=
er a
single 5&nbsp;mg/kg intravenous infusion of crizanlizumab in healthy
volunteers.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>Biotransformation</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Antibodies are primarily
eliminated via proteolysis by lysosomal enzymes in the liver to small pepti=
des
and amino acids.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>Elimination</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>In healthy volunteers, the=
 mean
terminal elimination half&#8209;life (T<sub></sub>) was 10.6&nbsp;days and=
 the
mean clearance was 11.7&nbsp;ml/h at crizanlizumab dose level 5&nbsp;mg/kg.=
 In
patients with sickle cell disease, the mean elimination T<sub></sub> durin=
g the
dosing interval was 7.5&nbsp;days.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>Linearity/non&#8209;linearity</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<=
sub>last</sub>,
or AUC<sub>inf</sub>) increased in non&#8209;linear manner over the dose ra=
nge
of 0.2 to 8&nbsp;mg/kg in healthy volunteers.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>Special
populations</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no=
-proof:
yes'>Renal impairment</span></u></i><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>In a population PK analysi=
s in
patients with eGFR ranging from 35 to 202&nbsp;ml/min/1.73&nbsp;m<sup>2</su=
p>,
no clinically important differences in the pharmacokinetics of crizanlizumab
were found between patients with mild or moderate renal impairment and pati=
ents
with normal renal function. Data from patients with severe renal impairment=
 are
too limited to draw conclusions on this population (see section</span><span
lang=3DEN-GB>&nbsp;</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>4.2).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><i><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no=
-proof:
yes'>Hepatic impairment</span></u></i><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>The safety and efficacy of crizanlizumab in patients with
hepatic impairment have not been established. Crizanlizumab is a monoclonal
antibody and is cleared via catabolism (i.e. breakdown into peptides and am=
ino
acids), and a change in dose is not expected to be required for patients wi=
th
hepatic impairment.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Paediatric <a
name=3D"_nth_Pediatric_patients__be14752"></a>population</span></u></i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>Pharmacokinetics in paediatric patients below the age of =
16&nbsp;years
have not been investigated.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>5.3<span style=3D'mso-tab-count:1'> </span>Pre=
clinical
safety data</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>N</span><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>on&#8209;clinical data rev=
ealed no
special hazard for humans based on conventional studies of safety pharmacol=
ogy,
tissue cross&#8209;reactivity and repeated dose toxicity.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>In the 26&#8209;week repea=
ted dose
toxicity study, administration of crizanlizumab in cynomolgus monkeys at do=
se
levels up to 50&nbsp;mg/kg/dose once every 4&nbsp;weeks (at least
13.5&nbsp;times the human clinical exposure based on AUC in patients with
sickle cell disease at 5&nbsp;mg/kg once every four weeks) was generally we=
ll tolerated.
There were no primary crizanlizumab&#8209;related findings on any endpoint
evaluated. At 50&nbsp;mg/kg, minimal to moderate inflammation of the vessel=
s in
multiple tissues considered to be an antigen&#8209;antibody complex reaction
(primate antihuman antibody) was observed in 2 of 10&nbsp;animals. There wa=
s one
death attributed to aspiration of gastric contents following a peri&#8209;i=
nfusional
reaction mediated by anti&#8209;drug&#8209;antibody&#8209;dependent
hypersensitivity.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'>Pharmacological
effects of crizanlizumab on haemodynamic and electrocardiographic parameter=
s in
the cynomolgus monkey were evaluated in the 26&#8209;week repeated dose
toxicology study. Respiratory rate and neurological parameters were also
assessed. There were no crizanlizumab&#8209;related effects on arterial blo=
od
pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QT=
c)
intervals on the electrocardiograms (ECG). No rhythm abnormalities or
qualitative changes were observed during the qualitative ECG assessment. Th=
ere
were no crizanlizumab&#8209;related effects on respiration rate or any
neurological parameter evaluated.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Formal carcinogenicity,
genotoxicity and juvenile toxicity studies have not been conducted with
crizanlizumab.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>In a 26&#8209;week repeate=
d dose
toxicity study, cynomolgus monkeys were administered crizanlizumab once eve=
ry 4&nbsp;weeks
at doses up to 50&nbsp;mg/kg (at least 13.5&nbsp;times the human clinical
exposure based on AUC in patients with sickle cell disease at 5&nbsp;mg/kg =
once
every four weeks). </span><span lang=3DEN-GB>There were no adverse effects =
of
crizanlizumab on male and female reproductive organs</span><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>In an enh=
anced
pre&#8209; and postnatal development study in cynomolgus monkeys, pregnant
animals received intravenous crizanlizumab once every two weeks during the
period of organogenesis, at doses of 10 and 50&nbsp;mg/kg (approximately 2.8
and 16&nbsp;times </span><span lang=3DEN-GB>the human clinical exposure bas=
ed on
AUC in patients with sickle cell disease at 5&nbsp;mg/kg/dose once every fo=
ur
weeks, respectively)</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt;
mso-no-proof:yes'>. No maternal toxicity was observed. </span><span lang=3D=
EN-GB>There
was an increase in foetal loss (abortions or stillbirths) at both doses and
this was higher in the third trimester. The cause of the foetal losses in
monkeys is unknown but may be due to the development of anti&#8209;drug
antibodies against crizanlizumab</span><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'>. There were no effects on infant growth and
development during the 6&nbsp;months postpartum that were attributable to
crizanlizumab.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Measurable
crizanlizumab serum concentrations were observed in the infant monkeys at
postnatal day&nbsp;28, confirming that crizanlizumab, like other IgG
antibodies, crosses the placental barrier.</span><span style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-hyphenate:none;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'> </span>PH=
ARMACEUTICAL
PARTICULARS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.1<span style=3D'mso-tab-count:1'> </span>Lis=
t of
excipients</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Sucrose<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Sodium
citrate (E331)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Citric
acid (E330)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Polysorbate
80 (E433)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Water for
injections<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.2<span style=3D'mso-tab-count:1'> </span>Inc=
ompatibilities</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>This medicinal product</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> must not be mixed with
other medicinal products except those mentioned in section&nbsp;6.6.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.3<span style=3D'mso-tab-count:1'> </span>She=
lf
life</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no=
-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Unopened vial</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>18&nbsp;months<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Diluted solution</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-s=
ize:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Chemical
and physical in&#8209;use stability, from the start of preparation of the
diluted solution for infusion until end of infusion, has been demonstrated =
for
up to 8&nbsp;hours at room temperature (up to 25C) and at 2C to 8C for u=
p to
24&nbsp;hours overall.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt;mso-no-proof:yes'>From a microbiological point of=
 view,
the diluted solution for infusion should be used immediately. If not used
immediately, in&#8209;use storage times and conditions prior to use are the
responsibility of the user and would normally not be longer than 24&nbsp;ho=
urs at
2C to 8C, including 4.5&nbsp;hours at room temperature (up to 25C) from =
the
start of preparation to completion of the infusion, unless dilution has tak=
en
place in controlled and validated aseptic conditions.</span><span
style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-langu=
age:
EN-US;mso-bidi-language:MY'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.4<span style=3D'mso-tab-count:1'> </span>Spe=
cial
precautions for storage</span></b><span lang=3DEN-GB style=3D'mso-bidi-font=
-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Store in =
a refrigerator
(2C&nbsp;&nbsp;8C).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not fr=
eeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep the =
vial in
the outer carton in order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>For stora=
ge conditions
after dilution of the medicinal product, see section&nbsp;6.3.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.5<span style=3D'mso-tab-count:1'> </span>Nat=
ure
and contents of container</span></b><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>10&nbsp;ml
concentrate for solution for infusion in a type&nbsp;I glass vial with a co=
ated
chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip=
&#8209;off
disk containing 100&nbsp;mg crizanlizumab.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Pack
of 1&nbsp;vial.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><a
name=3D"OLE_LINK1"><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.6<span style=3D'mso-=
tab-count:
1'> </span>Special precautions for disposal and other handling</span></=
b></a><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo vials are for =
single
use only.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Preparing the infusion=
</span></u></span><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'>The diluted solution for infusion should be prepared by a
healthcare professional using aseptic techniques.<o:p></o:p></span></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'>The total dose and required volume of Adakveo depend on t=
he patients
body weight; 5&nbsp;mg of crizanlizumab is administered per kg body weight.=
<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_L=
INK1'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>The volum=
e to be
used for the preparation of the infusion is calculated according to the
following equation:<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK=
1'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></span></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D567
 style=3D'margin-left:12.5pt;border-collapse:collapse;mso-table-layout-alt:=
fixed;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D113 rowspan=3D2 style=3D'width:85.05pt;padding:0in 5.4pt 0in =
5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;
  line-height:normal;mso-pagination:widow-orphan lines-together;page-break-=
after:
  avoid;mso-outline-level:1;tab-stops:28.35pt'><span style=3D'mso-bookmark:=
OLE_LINK1'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Volume (ml) =3D<span
  style=3D'mso-no-proof:yes'><o:p></o:p></span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D359 style=3D'width:269.35pt;border:none;border-bottom:solid w=
indowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-ali=
gn:center;
  text-indent:-28.35pt;line-height:normal;mso-pagination:widow-orphan lines=
-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
  11.0pt;mso-no-proof:yes'>Patients body weight (kg) x prescribed dose<o:p=
></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D94 style=3D'width:70.85pt;border:none;border-bottom:solid win=
dowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-ali=
gn:center;
  text-indent:-28.35pt;line-height:normal;mso-pagination:widow-orphan lines=
-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
  11.0pt;mso-no-proof:yes'>[5&nbsp;mg/kg]<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1;mso-yfti-lastrow:yes'>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D359 style=3D'width:269.35pt;border:none;mso-border-top-alt:so=
lid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dcenter style=3D'margin-top:0in;text-align:center;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'font-size:11=
.0pt;
  mso-ansi-language:EN-GB'>Concentration of Adakveo<o:p></o:p></span></span=
></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D94 style=3D'width:70.85pt;border:none;mso-border-top-alt:soli=
d windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dcenter style=3D'margin-top:0in;text-align:center;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'font-size:11=
.0pt;
  mso-ansi-language:EN-GB'>[10&nbsp;mg/ml]<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><a
name=3D"_hd6_Table_3_1_Example_of_d12477"></a><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK=
1'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span
style=3D'mso-tab-count:1'> </span>Obtain the number of vials required=
 to
deliver the prescribed dose and bring them to room temperature (for a maxim=
um
of 4&nbsp;hours). One vial is needed for every 10&nbsp;ml of Adakveo (see b=
elow
table).<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D568
 style=3D'margin-left:28.35pt;border-collapse:collapse;mso-table-layout-alt=
:fixed;
 border:none;mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:
 solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Body weight (kg)<o:p></o:p></span></b=
></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border-top:solid wind=
owtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Dose (mg)<o:p></o:p></span></b></span=
></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Volume (ml)<o:p></o:p></span></b></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Vials (n)<o:p></o:p></span></b></span=
></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>40<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>200<o:p=
></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>20<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>2<o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>60<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>300<o:p=
></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>30<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>3<o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>80<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>400<o:p=
></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>40<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>4<o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>100<o:p=
></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>500<o:p=
></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>50<o:p>=
</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookma=
rk:
  OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>5<o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
  11.0pt'>120<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
  11.0pt'>600<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
  11.0pt'>60<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span
  style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
  11.0pt'>6<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:OLE_LINK1'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span style=3D'mso-t=
ab-count:
1'> </span>Visually inspect the vials.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;line-=
height:
normal;mso-outline-level:1;mso-list:l10 level1 lfo42;tab-stops:28.35pt'><sp=
an
style=3D'mso-bookmark:OLE_LINK1'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The solution in the vials should be clear to opalescent. =
Do
not use if particles are present in the solution.<o:p></o:p></span></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;line-=
height:
normal;mso-outline-level:1;mso-list:l10 level1 lfo42;tab-stops:28.35pt'><sp=
an
style=3D'mso-bookmark:OLE_LINK1'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The solution should be colourless or may have a slight
brownish&#8209;yellow tint.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK=
1'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span
style=3D'mso-tab-count:1'> </span>Withdraw a volume equal to the requ=
ired
volume of Adakveo from a 100&nbsp;ml infusion bag containing either sodium
chloride 9&nbsp;mg/ml (0.9%) solution for injection or dextrose 5% and disc=
ard.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;mso-l=
ist:
l10 level1 lfo42;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'>=
<![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>No incompatibilities betw=
een
the diluted Adakveo solution and infusion bags composed of polyvinylchloride
(PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span><=
/span><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt'><span style=3D'mso-bookmar=
k:OLE_LINK1'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK=
1'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.<span
style=3D'mso-tab-count:1'> </span>Withdraw the necessary volume of Ad=
akveo from
the vials and inject slowly into the previously prepared infusion bag.<o:p>=
</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;mso-l=
ist:
l10 level1 lfo42;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'>=
<![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The </span><span lang=3DEN-GB>solution</span></span><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'> must not be mixed or co&#8209;administered with other me=
dicinal
products through the same intravenous line.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;mso-l=
ist:
l10 level1 lfo42;tab-stops:28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'>=
<![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>Keep the volume of Adakveo added to the infusion bag in t=
he
range of 10&nbsp;ml&nbsp;to&nbsp;96&nbsp;ml to obtain a final concentration=
 in
the infusion bag within 1&nbsp;mg/ml to 9.6&nbsp;mg/ml.<o:p></o:p></span></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span style=3D'mso-t=
ab-count:
1'> </span>Mix the diluted solution by gently inverting the infusion =
bag.
DO NOT SHAKE.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-=
style:
italic'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Administration</span><=
/u></span><a
name=3D"_nth_Administration25012"></a><span style=3D'mso-bookmark:OLE_LINK1=
'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'mso-bookmark:OLE_LINK1'><span style=3D'font-size:11.0pt'>Adakveo d=
iluted
solution must be administered through a sterile, non&#8209;pyrogenic 0.2&nb=
sp;micron
in&#8209;line filter by intravenous infusion over a period of 30&nbsp;minut=
es.</span></span><span
style=3D'mso-bookmark:OLE_LINK1'><span style=3D'font-size:11.0pt;mso-fareas=
t-font-family:
"Times New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US'> <span
lang=3DEN-GB>No incompatibilities have been observed between Adakveo and in=
fusion
sets composed of PVC, PE&#8209;lined PVC, polyurethane, and in&#8209;line
filter membranes composed of polyethersulfone (PES), polyamide (PA) or
polysulphone (PSU).<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'>After
administration of Adakveo, flush the line with at least 25&nbsp;ml sodium
chloride 9&nbsp;mg/ml (0.9%) solution for injection or dextrose 5%.<o:p></o=
:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Disposal</span></u></s=
pan><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'>Any unused medicinal product or waste material should be
disposed of in accordance with local requirements.<o:p></o:p></span></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p>&nbsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK1'></span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>7.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION HOLDER</spa=
n></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DDefault style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;color:windowtext;mso-ansi-language:EN-GB'>Novartis
Europharm Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'=
>Vista
Building<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'=
>Elm
Park, Merrion Road<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'=
>Dublin
4<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>Ireland<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>8.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S)</=
span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-family:Verdana;color:black'>EU/1/20/147=
6/001<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>9.<span
style=3D'mso-tab-count:1'> </span>DATE OF FIRST AUTHORISATION/RENEWAL=
 OF
THE AUTHORISATION</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>10.<span
style=3D'mso-tab-count:1'> </span>DATE OF REVISION OF THE TEXT</span></=
b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt'>Detailed information on this medicinal product is available on the
website of the European Medicines </span><span lang=3DEN-GB>Agency <a
href=3D"http://www.ema.europa.eu"><span style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>http://www.ema.europa.eu</span></a></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'>.<span style=3D'mso-no-proof:yes'><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>ANNEX II</span></b><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:70.8pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>A.<span
style=3D'mso-tab-count:1'> </span>MANUFACTURER(S) OF THE BIOLOGICAL AC=
TIVE
SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE<o:p></o:p></=
span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>B.<span
style=3D'mso-tab-count:1'> </span>CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY AND USE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>C.<span
style=3D'mso-tab-count:1'> </span>OTHER CONDITIONS AND REQUIREMENTS OF=
 THE
MARKETING AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:77.9pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>D.<span style=3D'mso-tab-count:1'> </span><span style=3D'=
text-transform:
uppercase'>conditions or restrictions with regard to the safe and effective=
 use
of the medicinal PRODUCT</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:70.8pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>E.<span style=3D'mso-tab-count:1'> </span>SPECIFIC OBLIGA=
TION TO
COMPLETE POST-AUTHORISATION MEASURES FOR THE </span></b><b style=3D'mso-bid=
i-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>CONDITIONAL</span><span
lang=3DEN-GB> MARKETING AUTHORISATION<o:p></o:p></span></b></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'pa=
ge-break-before:
always'>
</span>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>A.<span
style=3D'mso-tab-count:1'> </span>MANUFACTURER(S) OF THE BIOLOGICAL AC=
TIVE
SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE</span></b><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:70.8pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Name and address of the manufacturer(s) of the biological
active substance(s)<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:70.8pt;line-height:normal;page-b=
reak-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH;mso=
-no-proof:
yes'>Novartis Pharma AG<o:p></o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH;mso=
-no-proof:
yes'>Lichtstrasse 35<o:p></o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH;mso=
-no-proof:
yes'>4056 Basel<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH;mso=
-no-proof:
yes'>Switzerland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH;mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Name and address of the manufacturer(s) responsible for b=
atch
release</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso=
-no-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Novartis
Pharma GmbH<o:p></o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Roonstrasse
25<o:p></o:p></span></p>

<p class=3DStandard style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>90429
Nuremberg<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Germany<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><a name=3D"OLE_LINK2"><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>B.</span></b></a><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-tab-count:1'> </span>CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY AND USE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Medicinal=
 product
subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section&nbsp;4.2).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>C.<span style=3D'mso-t=
ab-count:
1'> </span>OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING
AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;page-b=
reak-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;page-break-after:avoid;mso-list:l36 level1 lfo21;tab-stops:28.35pt'>=
<![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fare=
ast-font-family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Periodic safety update rep=
orts
(PSURs)<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;page-=
break-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic'>The requirements for submission of PSURs for this medicinal product=
 are
set out in the list of Union reference dates (EURD list) </span><span
lang=3DEN-GB>provided for under Article 107c(7) of Directive 2001/83</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>/EC</span=
><span
lang=3DEN-GB> and </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-bidi-font-style:italic'>any subsequent updates published on the European
medicines web&#8209;portal.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB>The <span style=3D'mso-no-proof:yes'>marketing</span> authoris=
ation
holder (MAH) shall submit the first PSUR for this product within 6&nbsp;mon=
ths
following authorisation.</span><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-bidi-font-style:italic'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;tab-stops:28.35pt'><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DEN-GB>D.<span style=3D'mso-tab-count:1'> </span>C=
ONDITIONS
OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL
PRODUCT<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;page-b=
reak-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;page-break-after:avoid;mso-list:l36 level1 lfo21;tab-stops:28.35pt'>=
<![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Risk management plan (RMP)<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;page-b=
reak-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>The
</span><span lang=3DEN-GB style=3D'mso-no-proof:yes'>marketing</span><span
lang=3DEN-GB> authorisation holder<span style=3D'mso-no-proof:yes'> (</span=
></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>MAH) shall
perform the required pharmacovigilance activities and interventions detaile=
d in
the agreed RMP presented in Module 1.8.2 of the marketing authorisation and=
 any
agreed subsequent updates of the RMP.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic;mso-no-proof:yes'>An updated RMP should be submitted:<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;mso-list:l4 level1 lfo14;tab-stops:28.35pt'><![if !supportLists]><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fare=
ast-font-family:
Symbol;mso-bidi-font-family:Symbol;mso-bidi-font-style:italic;mso-no-proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'>At the request of the European
Medicines Agency;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal;mso-list:l4 level1 lfo14;tab-stops:28.35pt'><![if !supportLists]><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fare=
ast-font-family:
Symbol;mso-bidi-font-family:Symbol;mso-bidi-font-style:italic;mso-no-proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'>Whenever the risk management
system is modified, especially as the result of new information being recei=
ved
that may lead to a significant change to the benefit/risk profile or as the
result of an important (pharmacovigilance or risk minimisation) milestone b=
eing
reached.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-style:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'margin-right:-.05pt;line-height:normal;tab-sto=
ps:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DStandard style=3D'margin-left:28.35pt;text-indent:-28.35pt;line-=
height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>E.<span style=3D'mso-t=
ab-count:
1'> </span>SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES=
 FOR
THE CONDITIONAL MARKETING AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DStandard style=3D'line-height:normal;mso-pagination:widow-orphan=
 lines-together;
page-break-after:avoid;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DStandard style=3D'margin-right:-.05pt;line-height:normal;mso-pag=
ination:
widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>This being a conditional marketing authorisation and purs=
uant
to Article 14a(4) of Regulation (EC) No 726/2004, the MAH shall complete,
within the stated timeframe, the following measures:<o:p></o:p></span></p>

<p class=3DStandard style=3D'margin-right:-.05pt;line-height:normal;mso-pag=
ination:
widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DNormaleTabelle border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"100%"
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:480;mso-padding-alt:
 0in 5.4pt 0in 5.4pt;mso-border-insideh:.75pt solid windowtext;mso-border-i=
nsidev:
 .75pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D"82%" valign=3Dtop style=3D'width:82.18%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtex=
t .75pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DStandard style=3D'margin-right:-.05pt;line-height:normal;mso-p=
agination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-no-proof:yes'>Description<o:p></o:p></span></b></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.82%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .75pt;mso-border-al=
t:
  solid windowtext .5pt;mso-border-left-alt:solid windowtext .75pt;padding:
  0in 5.4pt 0in 5.4pt'>
  <p class=3DStandard style=3D'margin-right:-.05pt;line-height:normal;mso-p=
agination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-no-proof:yes'>Due date<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D"82%" valign=3Dtop style=3D'width:82.18%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .75pt;mso-border-alt:
  solid windowtext .75pt;mso-border-left-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt'>
  <p class=3DTabletextrowsAgency style=3D'line-height:normal;mso-pagination=
:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font=
-family:
  "Times New Roman",serif'>In order to confirm the efficacy and safety of
  crizanlizumab, the MAH should submit the results of the primary analysis =
of a
  phase III CSEG101A2301 study of crizanlizumab with or without
  hydroxyurea/hydroxycarbamide in adolescent and adult sickle cell disease
  patients with vaso-occlusive crises<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.82%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid windo=
wtext .75pt;
  mso-border-alt:solid windowtext .75pt;mso-border-right-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DTabletextrowsAgency style=3D'line-height:normal;mso-pagination=
:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font=
-family:
  "Times New Roman",serif'>Clinical study report primary analysis:<o:p></o:=
p></span></p>
  <p class=3DTabletextrowsAgency style=3D'line-height:normal;mso-pagination=
:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font=
-family:
  "Times New Roman",serif'>December 2025<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes;page-break-inside:avoid'>
  <td width=3D"82%" valign=3Dtop style=3D'width:82.18%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .75pt;mso-border-top-=
alt:
  .75pt;mso-border-left-alt:.5pt;mso-border-bottom-alt:.5pt;mso-border-righ=
t-alt:
  .75pt;mso-border-color-alt:windowtext;mso-border-style-alt:solid;padding:
  0in 5.4pt 0in 5.4pt'>
  <p class=3DTabletextrowsAgency style=3D'line-height:normal;mso-pagination=
:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font=
-family:
  "Times New Roman",serif'>In order to confirm the efficacy and safety of
  crizanlizumab, the MAH should submit the final results of the phase&nbsp;=
II
  CSEG101A2202 study of crizanlizumab with or without
  hydroxyurea/hydroxycarbamide in sickle cell disease patients with vaso&#8=
209;occlusive
  crisis.<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.82%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid windo=
wtext .75pt;
  mso-border-top-alt:.75pt;mso-border-left-alt:.75pt;mso-border-bottom-alt:
  .5pt;mso-border-right-alt:.5pt;mso-border-color-alt:windowtext;mso-border=
-style-alt:
  solid;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DTabletextrowsAgency style=3D'line-height:normal;mso-pagination=
:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font=
-family:
  "Times New Roman",serif'>Clinical study report:<o:p></o:p></span></p>
  <p class=3DTabletextrowsAgency style=3D'line-height:normal;mso-pagination=
:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font=
-family:
  "Times New Roman",serif'>December 2025<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>ANNEX III=
</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>LABELLING=
 AND
PACKAGE LEAFLET</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'mso-special-character:line-break;
page-break-before:always'>
</span></b>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>A. LABELL=
ING</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-color-alt:windowt=
ext;
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;backgrou=
nd:white'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING<o:p><=
/o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>CARTON</span></b><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;mso-bidi-font-weight:bold;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT</span=
></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo
10&nbsp;mg/ml concentrate for solution for infusion<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>crizanliz=
umab</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>2.<span
style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTIVE SUBSTANCE(S)<o:=
p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Each 10&n=
bsp;ml
vial contains 100&nbsp;mg crizanlizumab.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>3.<span
style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENTS</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Also cont=
ains:
sucrose, sodium citrate (E331), citric acid (E330), polysorbate 80 (E433),
water for injections.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.<span
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FORM AND CONTENTS</s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext;
background:#D9D9D9;mso-shading:windowtext;mso-pattern:gray-15 auto;mso-no-p=
roof:
yes'>Concentrate for solution for infusion</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1&nbsp;vi=
al<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>100&nbsp;=
mg/10&nbsp;ml<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>5.<span
style=3D'mso-tab-count:1'> </span>METHOD AND ROUTE(S) OF ADMINISTRATI=
ON</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>For intra=
venous
use after dilution.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Single us=
e.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Read the =
package
leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Keep
out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>7.<span
style=3D'mso-tab-count:1'> </span>OTHER SPECIAL WARNING(S), IF NECESS=
ARY</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt;border:
none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt=
 4.0pt 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>9.<span style=3D'mso-tab-count:1'> </span>SP=
ECIAL
STORAGE CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Store
in a refrigerator.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Do
not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep the =
vial in
the outer carton in order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:sol=
id windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF U=
NUSED
MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS,=
 IF
APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>11.<span
style=3D'mso-tab-count:1'> </span>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Novartis Eu=
ropharm
Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vista Build=
ing<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Elm Park, M=
errion
Road<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Dublin 4<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>12.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S)</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>EU/1/20/1476/001<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>13.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER</span></b><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Lot<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>14.<span
style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>16.<span
style=3D'mso-tab-count:1'> </span>INFORMATION IN BRAILLE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext;
background:#D9D9D9;mso-shading:windowtext;mso-pattern:gray-15 auto;mso-no-p=
roof:
yes'>Justification for not including Braille accepted.</span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:#CCCCCC;mso-no-p=
roof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:#CCCCCC;mso-no-p=
roof:
yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>17.<span
style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span>=
</b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext;
background:#D9D9D9;mso-shading:windowtext;mso-pattern:gray-15 auto;mso-no-p=
roof:
yes'>2D barcode carrying the unique identifier included.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>18.<span
style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DA=
TA</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>PC<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>SN<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>NN<span style=3D'mso-no-pr=
oof:yes'><o:p></o:p></span></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-color-alt:windowt=
ext;
background:#CCCCCC;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'mso-spec=
ial-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:#CCCCCC;mso-no-p=
roof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE P=
ACKAGING
UNITS<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>VIAL LABEL<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT AND
ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span l=
ang=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-no-proof:yes'>A=
dakveo
10&nbsp;mg/ml sterile concentrate<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span l=
ang=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-no-proof:yes'>c=
rizanlizumab<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>IV<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span
style=3D'mso-tab-count:1'> </span>METHOD OF ADMINISTRATION<o:p></o:p>=
</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p></o:p></span></b></=
p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>4.<span style=3D'mso-tab-c=
ount:1'> </span>BATCH
NUMBER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lot<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span
style=3D'mso-tab-count:1'> </span>CONTENTS BY WEIGHT, BY VOLUME OR BY=
 UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>100&nbsp;=
mg/10&nbsp;ml<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.<span
style=3D'mso-tab-count:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'mso-special-character:line-break;
page-break-before:always'>
</span></b>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>B. PACKAGE
LEAFLET<o:p></o:p></span></b></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'pa=
ge-break-before:
always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Package l=
eaflet:
Information for the patient</span></b><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip;tab-stops:28.35pt;background:white'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo
10&nbsp;mg/ml concentrate for solution for infusion</span></b><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;mso-no-proof:yes'>crizanlizumab<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'><v:shape id=3D"Picture_x=
0020_1"
 o:spid=3D"_x0000_i1025" type=3D"#_x0000_t75" alt=3D"BT_1000x858px" style=
=3D'width:15.75pt;
 height:13.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src=3D"Adakveo_clean_files/image001.png" o:title=3D"BT_1000x8=
58px"/>
</v:shape></span><span lang=3DEN-GB>This medicine is subject to additional
monitoring. This will allow quick identification of new safety information.=
 You
can help by reporting any side effects you may get. See the end of
section&nbsp;4 for how to report side effects.</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-sto=
ps:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>Read all of this leaflet carefully before you are
given this medicine because it contains important information for you.</spa=
n></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l0 level1 lfo15;tab-stops:28.35pt'><![if !supportLists]><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>Keep this leaflet. You may need to read it again.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l0 level1 lfo15;tab-stops:28.35pt'><![if !supportLists]><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>If you have any further questions, ask your doctor or nur=
se.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l0 level1 lfo15;tab-stops:28.35pt'><![if !supportLists]><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>If you get any side effects, talk to your doctor or nurse=
.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> This includes any possibl=
e side
effects not listed in this leaflet. See section&nbsp;4.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>What is i=
n this
leaflet</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso=
-no-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span
style=3D'mso-tab-count:1'> </span>What Adakveo is and what it is used=
 for<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span
style=3D'mso-tab-count:1'> </span>What you need to know before you are
given Adakveo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span
style=3D'mso-tab-count:1'> </span>How Adakveo is given<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.<span
style=3D'mso-tab-count:1'> </span>Possible side effects<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span
style=3D'mso-tab-count:1'> </span>How to store Adakveo<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.<span
style=3D'mso-tab-count:1'> </span>Contents of the pack and other
information<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span style=3D'mso-t=
ab-count:
1'> </span>What Adakveo is and what it is used for</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>What Adak=
veo is</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo <=
/span><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>contains
the active substance crizanlizumab, which belongs to a group of medicines
called monoclonal antibodies (mAbs).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes'>What Adakveo</span></b><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'mso-bidi-font-size:11.=
0pt;
mso-no-proof:yes'> </span></b><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>is
used for</span></b><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langua=
ge:
EN-US;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Adakveo</span><span
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> </span><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>is
used to prevent recurrent painful crises occurring in patients aged
16&nbsp;years and over with sickle cell disease. Adakveo can be given in
combination with hydroxyurea/hydroxycarbamide, although it may also be used
alone.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-bidi-font-we=
ight:
bold;mso-no-proof:yes'>Sickle cell disease is an inherited blood disorder</=
span><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>. It
causes affected red blood cells to become sickle&#8209;shaped and have
difficulty passing through small blood vessels. Additionally in sickle cell
disease the blood vessels are damaged and sticky due to ongoing chronic
inflammation. This leads to blood cells sticking to the blood vessels, caus=
ing
acute episodes of pain and organ damage.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes'>How Adakveo works</span></=
b><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Patients
with sickle cell disease have higher levels of a protein called P&#8209;sel=
ectin.
Adakveo binds P&#8209;selectin. This should stop blood cells sticking to the
vessel walls and help prevent painful crises.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>If
you have any questions about how Adakveo works or why this medicine has been
prescribed for you, ask your </span><a name=3D"_Toc312231909"></a><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>doctor or=
 nurse</span><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span style=3D'mso-t=
ab-count:
1'> </span>What you need to know before you are given Adakveo</span><=
/b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>You must =
not be
given Adakveo:</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;mso-no-proof:yes'>-<span style=3D'mso-tab-count:1'> </span>if=
 you
are allergic to crizanlizumab or any of the other ingredients of this medic=
ine
(listed in section&nbsp;6).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Warnings =
and
precautions</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Infusion
reactions</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Medicines of this type (called monoclonal antibodies) are
administered into a vein (intravenously) as an infusion. They can cause
unwanted reactions (side effects) when they are infused into your body. Such
reactions may happen within 24&nbsp;hours of receiving an infusion.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Tell your=
 doctor
or nurse immediately</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'> if you experience any of the following, which may be sig=
ns
of an infusion reaction:<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l14 level1 lfo29;tab-stops:
28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0p=
t "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>Fever, chills, shivering, nausea, vomiting, tiredness,
dizziness, pain where the infusion needle is inserted, blisters, itching,
shortness of breath or wheezing. See also section&nbsp;4, Possible side
effects.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Your doct=
or or
nurse may monitor you for signs and symptoms of such infusion reactions.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Blood tes=
ts
during Adakveo treatment</span></b><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you ne=
ed to
have any blood tests, tell the doctor or nurse that you are on treatment wi=
th Adakveo.
This is important because this treatment may interfere with a laboratory te=
st
used to measure the number of platelets in your blood.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt;
mso-no-proof:yes'>Children and adolescents</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'>Adakveo </span><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-bidi-font-weight:bold;mso-no-proof:yes'>should =
not
be used in children or adolescents below 16&nbsp;years of age.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt;mso-layout-grid-align:none;text-autospace:none'><b><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Calibri;mso-ansi=
-language:
EN-US'>Other medicines and Adakveo</span></b><span style=3D'mso-bidi-font-s=
ize:
11.0pt;mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-bidi-fon=
t-weight:
bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'>Tell your doctor or nurse if you are takin=
g,
have recently taken or might take any other medicines.</span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Pregnancy=
 and
breast&#8209;feeding</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'>Adakveo has not been tested in pregnant wo=
men
therefore there is limited information about its safety in pregnant women.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'>If you are pregnant, or are a woman who co=
uld
become pregnant and is not using contraception, it is not recommended to use
Adakveo.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'>It is not known whether </span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'>Adakveo </span><span style=3D'mso-bidi-font-size:11.0pt;
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US'>or its individual
ingredients pass into breast milk.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'mso-bidi-font-size:11.0pt;mso-fare=
ast-font-family:
Calibri;mso-ansi-language:EN-US'>If you are pregnant or breast&#8209;feedin=
g,
think you may be pregnant or are planning to have a baby, ask your doctor</=
span><span
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> </span><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Calibri;mso-ansi=
-language:
EN-US'>for advice before receiving this medicine. Your doctor will discuss =
with
you the potential risk(s) of </span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-bidi-font-weight:bold;mso-no-proof:yes'>Adakveo </span><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Calibri;mso-ansi=
-language:
EN-US'>during pregnancy or breast&#8209;feeding.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Drivin=
g and
using machines</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-fareast-font-family:Calibri'>Adakveo could have a minor effect on your
ability to drive and use machines. If you experience tiredness, drowsiness =
or
dizziness, do not drive or use machines until you feel better.</span><span
style=3D'mso-fareast-font-family:Calibri;mso-ansi-language:EN-US'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
mso-fareast-font-family:Calibri'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo c=
ontains
sodium</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-=
no-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Calibri;mso-ansi=
-language:
EN-US'>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per
vial, that is to say essentially sodium&#8209;free.</span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span style=3D'mso-t=
ab-count:
1'> </span>How Adakveo is given</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Adakveo
will be given to you by a doctor or nurse.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you ha=
ve any
questions about how Adakveo is given, ask the doctor or nurse who is giving=
 you
the infusion.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Your doct=
or will
tell you when you will have your infusions and follow&#8209;up appointments=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>How much Adakveo you w=
ill be
given</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-n=
o-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>The recom=
mended
dose is 5&nbsp;mg per kilogram of body weight. You will be given the first =
infusion
at Week&nbsp;0 and the second infusion two weeks later (Week&nbsp;2). After
that you will be given an infusion every 4&nbsp;weeks.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>How the infusion is gi=
ven</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo is
administered into a vein (intravenously) as an infusion lasting
30&nbsp;minutes.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Adakveo c=
an be given
alone or with hydroxyurea/hydroxycarbamide.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>How long Adakveo treat=
ment
lasts</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-n=
o-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>You should discuss with yo=
ur doctor<span
style=3D'mso-no-proof:yes'> </span>how long you will need to receive treatm=
ent.
Your doctor<span style=3D'mso-no-proof:yes'> </span>will regularly monitor =
your
condition to check that the treatment is having the desired effect.<span
style=3D'mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you forget a Adakve=
o infusion</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>It is very
important that you receive all your infusions. If you miss an appointment f=
or
an infusion, contact your doctor as soon as possible to reschedule.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you stop Adakveo tr=
eatment</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not st=
op Adakveo
treatment unless your doctor tells you that you can.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you ha=
ve any
further questions on the use of this medicine, ask your doctor or nurse.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>Possible side effec=
ts</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Like all
medicines, this medicine can cause side effects, although not everybody gets
them.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:1.5in;text-indent:-1.5in;line-hei=
ght:
normal;page-break-after:avoid;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>Some side effects could be serious</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Tell the =
doctor
or nurse giving you the infusion immediately</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> if you develop any of=
 the
following:<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l31 level1 lfo45;tab-stops:
28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0p=
t "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>Fever, chills, shivering, nausea, vomiting, tiredness,
dizziness, pain where the infusion needle is inserted, blisters, itching,
shortness of breath or wheezing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>These sym=
ptoms
can be signs of infusion reaction, which is a common side effect (this mean=
s it
may affect up to 1 in every 10&nbsp;people).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:1.5in;text-indent:-1.5in;line-hei=
ght:
normal;page-break-after:avoid;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'mso-bidi-font-size:11.=
0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>Other possible side effects</span=
></b><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-l=
anguage:
EN-US;mso-no-proof:yes'>Other possible side effects include those listed be=
low.
If these side effects become severe, tell your doctor or nurse.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-l=
anguage:
EN-US;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Very
common (may affect more than 1 in 10&nbsp;people)</span></b><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>pain in the joints (arthralgia)<o=
:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>nausea<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>back pain<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>fever<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>pain in the lower or upper abdome=
n,
feeling of tenderness in the abdomen and abdominal discomfort<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Common
(may affect up to 1 in every 10&nbsp;people)</span></b><span style=3D'mso-b=
idi-font-size:
11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>diarrhoea<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>itching (including vulvovaginal
itching)<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>vomiting<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>muscle pain (myalgia)<o:p></o:p><=
/span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>pain in the muscles or bones of t=
he
chest (musculoskeletal chest pain)<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>sore throat (oropharyngeal pain)<=
o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-28.35pt;line-height:normal;mso-list:l16 level1 lfo44;tab-stops:
28.35pt'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-=
<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:EN-US;mso-no-proof:yes'>redness or swelling and pain at t=
he
site of the infusion<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt'><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Reporting of side effe=
cts<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt'><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
9.0pt;mso-fareast-font-family:Verdana;mso-fareast-language:EN-GB'>If you get
any side effects, talk to your doctor or nurse. This includes any possible =
side
effects not listed in this leaflet.</span><span lang=3DEN-GB style=3D'font-=
size:
9.0pt;mso-fareast-font-family:Verdana;mso-fareast-language:EN-GB'> </span><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:9.0pt;mso-fareast-font-family:Verd=
ana;
mso-fareast-language:EN-GB'>You can also report side effects directly via <=
span
style=3D'color:black;mso-color-alt:windowtext;background:#D9D9D9'>the natio=
nal
reporting system listed in </span></span><span lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Verdana;backgrou=
nd:
#D9D9D9;mso-fareast-language:EN-GB'>Appendix V</span></a></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Ver=
dana;
mso-fareast-language:EN-GB'>.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
9.0pt;mso-fareast-font-family:Verdana;mso-fareast-language:EN-GB'> By repor=
ting
side effects you can help provide more information on the safety of this
medicine.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt'><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-layo=
ut-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>5.<span style=3D'mso-tab-count:1'> </span>Ho=
w to
store Adakveo</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
mso-no-proof:yes'>Do not use this medicine after the expiry date which is
stated on the outer carton and the label after EXP. The expiry date refer=
s to
the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep the =
vial in
the outer carton in order to protect from light. Store in a refrigerator
(2C&nbsp;&nbsp;8C). Do not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Infusion
solutions should be used immediately after dilution.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>6.<span style=3D'mso-tab-c=
ount:1'> </span>Contents
of the pack and other information</span></b><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What Adakveo contains</spa=
n></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-list:l0 level1 lfo15;tab-stops:28.35pt'><=
![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0p=
t "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substance is crizanlizumab.<span style=3D'mso-no-proof:yes'> Each
10&nbsp;ml vial contains 100&nbsp;mg of crizanlizumab.<span style=3D'mso-bi=
di-font-style:
italic'><o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-list:l0 level1 lfo15;tab-stops:28.35pt'><=
![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The other ingredients are sucrose, sodium citrate </span>=
<span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>(E331)</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>, citric =
acid
(E330), polysorbate 80 (E433) and water for injections.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What Adakveo looks like and
contents of the pack</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Adakveo concentrate for so=
lution
for infusion is a colourless to slightly brownish&#8209;yellow liquid.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Adakveo is available in pa=
cks
containing 1&nbsp;vial.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Marketing Authorisation Ho=
lder</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Novartis Europharm Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Vista Building<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Elm Park, Merrion Road<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>Dublin 4<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Ireland<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer</span></b><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;
mso-no-proof:yes'>Novartis Pharma GmbH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;
mso-no-proof:yes'>Roonstrasse 25<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;
mso-no-proof:yes'>90429 Nuremberg<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-no-proof:yes=
'>Germany<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>For any information ab=
out
this medicine, please contact the local representative of the Marketing
Authorisation Holder:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D0
 style=3D'margin-left:-1.7pt;border-collapse:collapse;mso-table-layout-alt:=
fixed;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR-BE style=3D'mso-bid=
i-font-size:
  11.0pt;mso-ansi-language:FR-BE'>Belgi/Belgique/Belgien<o:p></o:p></span>=
</b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR-BE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR-BE'>=
Novartis
  Pharma N.V.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR-BE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR-BE'>=
Tl/Tel:
  +32 2 246 16 11</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'><o:p>&=
nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DLT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:LT'>Lietuva<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>SIA No=
vartis
  Baltics Lietuvos filialas</span><span lang=3DLT style=3D'mso-bidi-font-si=
ze:11.0pt;
  mso-ansi-language:LT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DLT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:LT'>Tel: +=
370 5
  269 16 50<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR-CH'>=
<o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DBG style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:BG'>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#=
1080;&#1103;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'>Novart=
is
  Pharma Services Inc.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DBG style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:BG'>&#1058=
;&#1077;&#1083;:</span><span
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'> +359 2 489 9=
8 28</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DNO-BOK style=3D'mso-bi=
di-font-size:
  11.0pt;mso-ansi-language:NO-BOK'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE-CH style=3D'mso-bid=
i-font-size:
  11.0pt;mso-ansi-language:DE-CH'>Luxembourg/Luxemburg<o:p></o:p></span></b=
></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH'>=
Novartis
  Pharma N.V.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR-BE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR-BE'>=
Tl/Tel:
  +32 2 246 16 11</span><span lang=3DDE-CH style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:DE-CH'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DNO-BOK style=3D'mso-bidi-font-size:11.0pt;mso-ansi-=
language:
  NO-BOK'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>&#268;esk repub=
lika<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  SV'>Novartis s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-CH'>=
Tel:
  +420 225 775 111<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-l=
anguage:
  DE-CH'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DHU style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:HU'>Magyarorszg<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DHU style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:HU'>Novart=
is
  Hungria Kft. Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DHU style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  HU'>Tel.: +36 1 457 65 00</span><span lang=3DMT style=3D'mso-bidi-font-si=
ze:11.0pt;
  mso-ansi-language:MT'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:EN-US'>Danmark<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'>Novartis Heal=
thcare
  A/S<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'>Tlf: +45 39 1=
6 84
  00<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US=
'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DMT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:MT'>Malta<o:p></o:p>=
</span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DMT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:MT'>Novart=
is
  Pharma Services Inc.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DMT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:MT'>Tel: +=
</span><span
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'>356 </span><s=
pan
  lang=3DFR-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR-CH'>=
2122
  2872</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></=
o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Novart=
is
  Pharma GmbH<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 911
  273 0<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  DE'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DNL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:NL'>Nederland<o:p></=
o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DNL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:NL;mso-bid=
i-font-style:
  italic'>Novartis Pharma B.V.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DNL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:NL'>Tel: +=
31 88 04
  52 555</span><span lang=3DDE-CH style=3D'mso-bidi-font-size:11.0pt;mso-an=
si-language:
  DE-CH'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b><span lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-l=
anguage:
  ET'>Eesti<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  IT'>SIA Novartis Baltics Eesti filiaal</span><span lang=3DET style=3D'mso=
-bidi-font-size:
  11.0pt;mso-ansi-language:ET'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  ET'>Tel: +372 </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>66 30
  810</span><span lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
  ET'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  ET'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DNO-BOK style=3D'mso-bi=
di-font-size:
  11.0pt;mso-ansi-language:NO-BOK'>Norge<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DNO-BOK style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:NO-BOK=
'>Novartis
  Norge AS<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DNO-BOK style=3D'mso-bidi-font-size:11.0pt;mso-ansi-=
language:
  NO-BOK'>Tlf: +47 23 05 20 00</span><span lang=3DET style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:ET'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL'>&#917;&#955;&#955;&#940;&#948;&#945;</span><=
/b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DET style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:ET'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ET'>Novart=
is
  (Hellas) A.E.B.E.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#932;=
&#951;&#955;</span><span
  lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ET'>: +30 =
210 281
  17 12<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DET style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  ET'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE-AT style=3D'mso-bid=
i-font-size:
  11.0pt;mso-ansi-language:DE-AT'>sterreich<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DDE-AT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-AT'>=
Novartis
  Pharma GmbH<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DDE-AT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE-AT'>=
Tel: +43
  1 86 6570</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-an=
si-language:
  DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Espaa<o:p></o:p=
></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Novart=
is
  Farmacutica, S.A.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Tel: +=
34 93
  306 42 00<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  ES'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:7;mso-=
hyphenate:
  none;tab-stops:28.35pt'><b><span lang=3DPL style=3D'mso-bidi-font-size:11=
.0pt;
  mso-ansi-language:PL;mso-bidi-font-style:italic'>Polska<o:p></o:p></span>=
</b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DPL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:PL'>Novart=
is
  Poland Sp. z o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DPL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:PL'>Tel.: =
+48 22 375
  4888<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'>France<o:p></o:p=
></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'>Novart=
is
  Pharma S.A.S.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'>Tl: +=
33 1 55
  47 66 00<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FR'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DPT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:PT'>Portugal<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:PT'>Novart=
is Farma
  &#8209; Produtos Farmacuticos, S.A.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  PT'>Tel: +351 21 000 8600</span><span lang=3DDE-CH style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:DE-CH'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-fareast-font-family:PMingLiU;mso-ansi-language:SV'>Hrvatska<o:=
p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Novart=
is
  Hrvatska d.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel. +385 1 6274 220<o:p=
></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-la=
yout-grid-align:
  none;text-autospace:none'><b><span lang=3DFR-CH style=3D'mso-bidi-font-si=
ze:11.0pt;
  mso-ansi-language:FR-CH'>Romnia<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt;mso-la=
yout-grid-align:
  none;text-autospace:none'><span lang=3DFR-CH style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FR-CH'>Novartis Pharma Services Romania SRL<o:p></o:p><=
/span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US=
'>Tel:
  +40 21 31299 01</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Ireland<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Novartis Ireland Limited=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 260 12 55<o:=
p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SL'>Slovenija<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SL'>Novart=
is
  Pharma Services Inc.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SL'>Tel: +=
386 1
  300 75 50<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIS style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IS'>sland<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DIS style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IS'>Vistor=
 hf.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pro=
of:yes'>Smi</span><span
  lang=3DIS style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IS'>: +354=
 535
  7000<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span>=
</p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DSK
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SK'>Slovensk republ=
ika<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSK style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SK'>Novart=
is
  Slovakia s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSK style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SK'>Tel: +=
421 2
  5542 5439<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DSK style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  SK'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DPT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:PT'>Italia<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:PT'>Novart=
is Farma
  S.p.A.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Tel: +=
39 02 96
  54 1</span><b style=3D'mso-bidi-font-weight:normal'><span lang=3DPT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:PT'><o:p></o:p></spa=
n></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Suomi/Finland<o:=
p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Novart=
is
  Finland Oy<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Puh/Te=
l: +358 </span><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-bid=
i-language:
  HE'>(0)10 6133 200</span><span lang=3DSV style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  SV'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL'>&#922;&#973;&#960;&#961;&#959;&#962;</span><=
/b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR-CH style=3D'mso-bid=
i-font-size:
  11.0pt;mso-ansi-language:FR-CH'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DFR-CH style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR-CH'>=
Novartis
  Pharma Services Inc.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  EL'>&#932;&#951;&#955;: +357 22 690 690<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Sverige<o:p></o:=
p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Novart=
is
  Sverige AB<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Tel: +=
46 8 732
  32 00<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  FI'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DLV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:LV'>Latvija<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-no-=
proof:
  yes'>SIA Novartis Baltics</span><span lang=3DLV style=3D'mso-bidi-font-si=
ze:11.0pt;
  mso-ansi-language:LV'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DLV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  LV'>Tel: +371 67 887 070<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
  IT'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>United Kingdom<o=
:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Novart=
is
  Pharmaceuticals UK Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-s=
tops:
  28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 =
1276
  698370<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US'><o:p>&nbsp;</=
o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>This leaflet was last
revised in</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>This medicine has been given conditional approval. This
means that there is more evidence to come about this medicine.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'>The European Medicines Agency will review new information=
 on
this medicine at least every year and this leaflet will be updated as
necessary.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Other sou=
rces of
information</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Detailed information on th=
is
medicine is available on the European Medicines Agency web site: </span><sp=
an
lang=3DEN-GB><span style=3D'mso-field-code:" HYPERLINK "'><span class=3DMso=
Hyperlink><span
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>http://www.ema.europa.=
eu</span></span></span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'pa=
ge-break-before:
always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>The following information is intended for healthca=
re
professionals only:</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Adakveo
vials are for single use only.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Preparing the infusion</span></u><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>The dilut=
ed
solution for infusion <span style=3D'mso-spacerun:yes'></span>should be pr=
epared
by a healthcare professional using aseptic techniques.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>The total=
 dose
and required volume of Adakveo depend on the patients body weight; 5&nbsp;=
mg
of crizanlizumab is administered per kg body weight.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>The
volume to be used for the preparation of the infusion is calculated accordi=
ng
to the following equation:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D567
 style=3D'margin-left:12.5pt;border-collapse:collapse;mso-table-layout-alt:=
fixed;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D113 rowspan=3D2 style=3D'width:85.05pt;padding:0in 5.4pt 0in =
5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;
  line-height:normal;mso-pagination:widow-orphan lines-together;page-break-=
after:
  avoid;mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Volume (ml) =3D<span style=3D'mso-no-=
proof:
  yes'><o:p></o:p></span></span></p>
  </td>
  <td width=3D359 style=3D'width:269.35pt;border:none;border-bottom:solid w=
indowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-ali=
gn:center;
  text-indent:-28.35pt;line-height:normal;mso-pagination:widow-orphan lines=
-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Patient=
s body
  weight (kg) x prescribed dose<o:p></o:p></span></p>
  </td>
  <td width=3D94 style=3D'width:70.85pt;border:none;border-bottom:solid win=
dowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-ali=
gn:center;
  text-indent:-28.35pt;line-height:normal;mso-pagination:widow-orphan lines=
-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>[5&nbsp=
;mg/kg]<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;mso-yfti-lastrow:yes'>
  <td width=3D359 style=3D'width:269.35pt;border:none;mso-border-top-alt:so=
lid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dcenter style=3D'margin-top:0in;text-align:center;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid'><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Concentra=
tion of Adakveo<o:p></o:p></span></p>
  </td>
  <td width=3D94 style=3D'width:70.85pt;border:none;mso-border-top-alt:soli=
d windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DText align=3Dcenter style=3D'margin-top:0in;text-align:center;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid'><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>[10&nbsp;=
mg/ml]<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span>Ob=
tain
the number of vials required to deliver the prescribed dose and bring them =
to
room temperature (for a maximum of 4&nbsp;hours). One vial is needed for ev=
ery
10&nbsp;ml of Adakveo (see below table).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D568
 style=3D'margin-left:28.35pt;border-collapse:collapse;mso-table-layout-alt=
:fixed;
 border:none;mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:
 solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Body weigh=
t (kg)<o:p></o:p></span></b></p>
  </td>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border-top:solid wind=
owtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Dose (mg)<=
o:p></o:p></span></b></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Volume (ml=
)<o:p></o:p></span></b></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border-top:solid win=
dowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:solid wind=
owtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vials (n)<=
o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>40<o:p></o:p></span></p>
  </td>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>200<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>20<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>2<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>60<o:p></o:p></span></p>
  </td>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>300<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>30<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>3<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>80<o:p></o:p></span></p>
  </td>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>400<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>40<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>4<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>100<o:p></o:p></span></p>
  </td>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;padding:0=
in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>500<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>50<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;padding:=
0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-=
pagination:
  widow-orphan lines-together;page-break-after:avoid;tab-stops:28.35pt;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>5<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;page-break-inside:avoid'>
  <td width=3D140 valign=3Dtop style=3D'width:104.65pt;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>120<o:p></o:p></span></p>
  </td>
  <td width=3D123 valign=3Dtop style=3D'width:92.15pt;border:none;border-bo=
ttom:solid windowtext 1.0pt;
  mso-border-bottom-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>600<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>60<o:p></o:p></span></p>
  </td>
  <td width=3D153 valign=3Dtop style=3D'width:114.75pt;border:none;border-b=
ottom:
  solid windowtext 1.0pt;mso-border-bottom-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-=
stops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>6<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'> </span>Visually
inspect the vials.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;line-=
height:
normal;mso-outline-level:1;mso-list:l10 level1 lfo42;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The solution in the vials should be clear to opalescent. =
Do
not use if particles are present in the solution.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;line-=
height:
normal;mso-outline-level:1;mso-list:l10 level1 lfo42;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The solution should be colourless or may have a slight
brownish&#8209;yellow tint.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span>Wi=
thdraw
a volume equal to the required volume of Adakveo from a 100&nbsp;ml infusion
bag containing either sodium chloride </span><span lang=3DEN-GB>9&nbsp;mg/m=
l (</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>0.9%) sol=
ution
for injection or dextrose 5% and discard.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;mso-l=
ist:
l10 level1 lfo42;tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>No incompatibilities betw=
een
the diluted Adakveo solution and infusion bags composed of polyvinylchloride
(PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt'><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan lines-together;page-break-after:avoid;
mso-outline-level:1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'>4.<span style=3D'mso-tab-count:1'> </span>Wi=
thdraw
the necessary volume of Adakveo from the vials and inject slowly into the
previously prepared infusion bag.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;mso-l=
ist:
l10 level1 lfo42;tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The </span><span lang=3DEN-GB>solution</span><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> must not be mixed or =
co&#8209;administered
with other medicinal products through the same intravenous line.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;text-indent:-28.35pt;mso-l=
ist:
l10 level1 lfo42;tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>Keep the volume of Adakveo added to the infusion bag in t=
he
range of 10&nbsp;ml&nbsp;to&nbsp;96&nbsp;ml to obtain a final concentration=
 in
the infusion bag within 1&nbsp;mg/ml to 9.6&nbsp;mg/ml.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>5.<span
style=3D'mso-tab-count:1'> </span>Mix the diluted solution by gently
inverting the infusion bag. DO NOT SHAKE.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-fon=
t-weight:
bold;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'ms=
o-bidi-font-size:
11.0pt;mso-no-proof:yes'>Storage of the diluted solution</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>Chemical
and physical in&#8209;use stability, from the start of preparation of the
diluted solution for infusion until end of infusion, has been demonstrated =
for
up to 8&nbsp;hours at room temperature (up to 25C) and at 2C to 8C for u=
p to
24&nbsp;hours overall.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;tab-st=
ops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof=
:yes'>From
a microbiological point of view, the diluted solution for infusion should be
used immediately. If not used immediately, in&#8209;use storage times and
conditions prior to use are the responsibility of the user and would normal=
ly
not be longer than 24&nbsp;hours at 2C to 8C, including 4.5&nbsp;hours at
room temperature (up to 25C) from the start of preparation to completion of
the infusion, unless dilution has taken place in controlled and validated
aseptic conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN-US;mso-bidi-font-we=
ight:
bold;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Administration</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB>Adakveo diluted </span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
12.0pt'>solution must be administered through a sterile, non&#8209;pyrogeni=
c 0.2&nbsp;micron
in&#8209;line filter</span><span lang=3DEN-GB> by intravenous infusion over=
 a
period of 30&nbsp;minutes.</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt'> No incompatibilities have been observed between Adakveo and infusi=
on
sets composed of PVC, PE&#8209;lined PVC, polyurethane, and in&#8209;line
filter membranes composed of polyethersulfone (PES), polyamide (PA) or
polysulphone (PSU).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>After administration of Ad=
akveo,
flush the line with at least 25&nbsp;ml sodium chloride 9&nbsp;mg/ml (0.9%)=
 solution
for injection or dextrose 5%.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>Disposal</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;page-break-after:avoid;mso-outline-level:1;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Any unused
product or waste material should be disposed of in accordance with local
requirements.<o:p></o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><p:properties xmlns:p=3D"http://s=
chemas.microsoft.com/office/2006/metadata/properties" xmlns:xsi=3D"http://w=
ww.w3.org/2001/XMLSchema-instance" xmlns:pc=3D"http://schemas.microsoft.com=
/office/infopath/2007/PartnerControls"><documentManagement/></p:properties>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{74F9A617-04E9-4A0F-90FD-0B18B0540068}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/properties"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.c=
om/office/infopath/2007/PartnerControls"/></ds:schemaRefs></ds:datastoreIte=
m>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/item0003.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?mso-contentType?><FormTemplates xmlns=3D"http://schemas.microsoft.com/sha=
repoint/v3/contenttype/forms"><Display>DocumentLibraryForm</Display><Edit>D=
ocumentLibraryForm</Edit><New>DocumentLibraryForm</New></FormTemplates>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/props004.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{7C931BE8-7762-4EA9-9D61-0B9576D0E211}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/sharepoin=
t/v3/contenttype/forms"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/item0005.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><ct:contentTypeSchema ct:_=3D"" m=
a:_=3D"" ma:contentTypeName=3D"Document" ma:contentTypeID=3D"0x010100726F91=
DD1AE57B44B1BCEB7F1056F5D0" ma:contentTypeVersion=3D"6" ma:contentTypeDescr=
iption=3D"Create a new document." ma:contentTypeScope=3D"" ma:versionID=3D"=
80d1dd17cb0c17b7740334051d5d16b2" xmlns:ct=3D"http://schemas.microsoft.com/=
office/2006/metadata/contentType" xmlns:ma=3D"http://schemas.microsoft.com/=
office/2006/metadata/properties/metaAttributes">
<xsd:schema targetNamespace=3D"http://schemas.microsoft.com/office/2006/met=
adata/properties" ma:root=3D"true" ma:fieldsID=3D"c170dc105f61f60cf84b7b3e6=
d807e4f" ns2:_=3D"" ns3:_=3D"" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchem=
a" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:p=3D"http://schemas.=
microsoft.com/office/2006/metadata/properties" xmlns:ns2=3D"a6a35199-84b7-4=
ca5-aa1c-39e9ca4c46ff" xmlns:ns3=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9">
<xsd:import namespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/>
<xsd:import namespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"/>
<xsd:element name=3D"properties">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"documentManagement">
<xsd:complexType>
<xsd:all>
<xsd:element ref=3D"ns2:MediaServiceMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceFastMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceAutoKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithUsers" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithDetails" minOccurs=3D"0"/>
</xsd:all>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"MediaServiceMetadata" ma:index=3D"8" nillable=3D"true"=
 ma:displayName=3D"MediaServiceMetadata" ma:hidden=3D"true" ma:internalName=
=3D"MediaServiceMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceFastMetadata" ma:index=3D"9" nillable=3D"t=
rue" ma:displayName=3D"MediaServiceFastMetadata" ma:hidden=3D"true" ma:inte=
rnalName=3D"MediaServiceFastMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceAutoKeyPoints" ma:index=3D"10" nillable=3D=
"true" ma:displayName=3D"MediaServiceAutoKeyPoints" ma:hidden=3D"true" ma:i=
nternalName=3D"MediaServiceAutoKeyPoints" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceKeyPoints" ma:index=3D"11" nillable=3D"tru=
e" ma:displayName=3D"KeyPoints" ma:internalName=3D"MediaServiceKeyPoints" m=
a:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"SharedWithUsers" ma:index=3D"12" nillable=3D"true" ma:=
displayName=3D"Shared With" ma:internalName=3D"SharedWithUsers" ma:readOnly=
=3D"true">
<xsd:complexType>
<xsd:complexContent>
<xsd:extension base=3D"dms:UserMulti">
<xsd:sequence>
<xsd:element name=3D"UserInfo" minOccurs=3D"0" maxOccurs=3D"unbounded">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"DisplayName" type=3D"xsd:string" minOccurs=3D"0"/>
<xsd:element name=3D"AccountId" type=3D"dms:UserId" minOccurs=3D"0" nillabl=
e=3D"true"/>
<xsd:element name=3D"AccountType" type=3D"xsd:string" minOccurs=3D"0"/>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:extension>
</xsd:complexContent>
</xsd:complexType>
</xsd:element>
<xsd:element name=3D"SharedWithDetails" ma:index=3D"13" nillable=3D"true" m=
a:displayName=3D"Shared With Details" ma:internalName=3D"SharedWithDetails"=
 ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"http://schemas.openxmlformats.org/package/20=
06/metadata/core-properties" elementFormDefault=3D"qualified" attributeForm=
Default=3D"unqualified" blockDefault=3D"#all" xmlns=3D"http://schemas.openx=
mlformats.org/package/2006/metadata/core-properties" xmlns:xsd=3D"http://ww=
w.w3.org/2001/XMLSchema" xmlns:xsi=3D"http://www.w3.org/2001/XMLSchema-inst=
ance" xmlns:dc=3D"http://purl.org/dc/elements/1.1/" xmlns:dcterms=3D"http:/=
/purl.org/dc/terms/" xmlns:odoc=3D"http://schemas.microsoft.com/internal/ob=
d">
<xsd:import namespace=3D"http://purl.org/dc/elements/1.1/" schemaLocation=
=3D"http://dublincore.org/schemas/xmls/qdc/2003/04/02/dc.xsd"/>
<xsd:import namespace=3D"http://purl.org/dc/terms/" schemaLocation=3D"http:=
//dublincore.org/schemas/xmls/qdc/2003/04/02/dcterms.xsd"/>
<xsd:element name=3D"coreProperties" type=3D"CT_coreProperties"/>
<xsd:complexType name=3D"CT_coreProperties">
<xsd:all>
<xsd:element ref=3D"dc:creator" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dcterms:created" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:identifier" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentType" minOccurs=3D"0" maxOccurs=3D"1" type=3D"x=
sd:string" ma:index=3D"0" ma:displayName=3D"Content Type"/>
<xsd:element ref=3D"dc:title" minOccurs=3D"0" maxOccurs=3D"1" ma:index=3D"4=
" ma:displayName=3D"Title"/>
<xsd:element ref=3D"dc:subject" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:description" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"keywords" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element ref=3D"dc:language" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"category" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element name=3D"version" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:s=
tring"/>
<xsd:element name=3D"revision" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string">
<xsd:annotation>
<xsd:documentation>
                        This value indicates the number of saves or revisio=
ns. The application is responsible for updating this value after each revis=
ion.
                    </xsd:documentation>
</xsd:annotation>
</xsd:element>
<xsd:element name=3D"lastModifiedBy" minOccurs=3D"0" maxOccurs=3D"1" type=
=3D"xsd:string"/>
<xsd:element ref=3D"dcterms:modified" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentStatus" minOccurs=3D"0" maxOccurs=3D"1" type=3D=
"xsd:string"/>
</xsd:all>
</xsd:complexType>
</xsd:schema>
<xs:schema targetNamespace=3D"http://schemas.microsoft.com/office/infopath/=
2007/PartnerControls" elementFormDefault=3D"qualified" attributeFormDefault=
=3D"unqualified" xmlns:pc=3D"http://schemas.microsoft.com/office/infopath/2=
007/PartnerControls" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema">
<xs:element name=3D"Person">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:DisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountId" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountType" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"DisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountId" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountType" type=3D"xs:string"></xs:element>
<xs:element name=3D"BDCAssociatedEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:BDCEntity" minOccurs=3D"0" maxOccurs=3D"unbounded"></=
xs:element>
</xs:sequence>
<xs:attribute ref=3D"pc:EntityNamespace"></xs:attribute>
<xs:attribute ref=3D"pc:EntityName"></xs:attribute>
<xs:attribute ref=3D"pc:SystemInstanceName"></xs:attribute>
<xs:attribute ref=3D"pc:AssociationName"></xs:attribute>
</xs:complexType>
</xs:element>
<xs:attribute name=3D"EntityNamespace" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"EntityName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"SystemInstanceName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"AssociationName" type=3D"xs:string"></xs:attribute>
<xs:element name=3D"BDCEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:EntityDisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityInstanceReference" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId1" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId2" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId3" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId4" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId5" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"EntityDisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityInstanceReference" type=3D"xs:string"></xs:elemen=
t>
<xs:element name=3D"EntityId1" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId2" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId3" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId4" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId5" type=3D"xs:string"></xs:element>
<xs:element name=3D"Terms">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermInfo" minOccurs=3D"0" maxOccurs=3D"unbounded"></x=
s:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermInfo">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:TermId" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermName" type=3D"xs:string"></xs:element>
<xs:element name=3D"TermId" type=3D"xs:string"></xs:element>
</xs:schema>
</ct:contentTypeSchema>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/props006.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{BFE2FC7B-42A1-4D76-8929-287E176203BB}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/contentType"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.=
com/office/2006/metadata/properties/metaAttributes"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/2001/XMLSchema"/><ds:schemaRef ds:uri=3D"http://schem=
as.microsoft.com/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"=
a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/><ds:schemaRef ds:uri=3D"0ac2e3cc-46b=
d-4320-b2ac-d7f7d167e1a9"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft=
.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http://=
schemas.microsoft.com/office/infopath/2007/PartnerControls"/><ds:schemaRef =
ds:uri=3D"http://schemas.openxmlformats.org/package/2006/metadata/core-prop=
erties"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/elements/1.1/"/><ds:sch=
emaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http:/=
/schemas.microsoft.com/internal/obd"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/item0007.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APASixthEditionOfficeOnline.xsl" StyleName=3D"APA" Version=3D=
"6" xmlns:b=3D"http://schemas.openxmlformats.org/officeDocument/2006/biblio=
graphy" xmlns=3D"http://schemas.openxmlformats.org/officeDocument/2006/bibl=
iography"></b:Sources>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/props008.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{D6B631A0-FEE4-40BB-AF82-9955DC3D4DE3}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/image001.png
Content-Transfer-Encoding: base64
Content-Type: image/png

iVBORw0KGgoAAAANSUhEUgAAADAAAAAqCAYAAAD1T9h6AAAAAXNSR0IArs4c6QAAAARnQU1BAACx
jwv8YQUAAAAJcEhZcwAAIdUAACHVAQSctJ0AAAFOSURBVGhD1djLjQIxEEVRb0gAoiAUgoFcIBcI
hSxIgAXgQmqpaZm+/pVdtlSamd27szhCOOfczd9r0Lv63W7v7+nvPdjJZtn+fZfBxss/+zyNl587
f4+BImTrdh4gv58GCjgux8vfG3/3ASJko2wNvsMAAbJx9QmrVkWSbfissvrDJlVYZFU2RT8hyhKr
QTapxhKrQTYpwAqrq2xShAVWkU2K6MlqFJsU0IvVJDYpogerSWxSQGtWs9ikiJasZrFJAa1YLWKT
IlqwWswmRWiyWoVNCtBitSqbFKHBalU2KaD2lwAqbFJETVZV2KSAWqyqskkRNVhVZ5MiSlhtwiYF
5LLalE2KyGG1KZsUkPpptQubFJHCahc2KSCW1a5sUkQMq93ZpIg1Vk2wSQH/WDXFJkWEWDXFJgUs
WTXJJkXMWTXJJgVMrJpmkyKETFU2P9CD7BYmSLNEAAAAAElFTkSuQmCC

------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/image002.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/image003.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../Adakveo_clean.htm">
<![if IE]>
<base href=3D"file:///C:/8467A08E/Adakveo_clean_files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3D"#954F72">

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-continuation-separator'><![if !supp=
ortFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-continuation-separator'><![if !supp=
ortFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ <span style=3D'mso-element:field-sepa=
rator'></span></span><![endif]--><!--[if supportFields]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'>13</span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

<div style=3D'mso-element:footer' id=3Dff1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ <span style=3D'mso-element:field-sepa=
rator'></span></span><![endif]--><!--[if supportFields]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'>1</span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

</body>

</html>

------=_NextPart_01D7475B.26890930
Content-Location: file:///C:/8467A08E/Adakveo_clean_files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../Adakveo_clean.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"item0003.xml"/>
 <o:File HRef=3D"props004.xml"/>
 <o:File HRef=3D"item0005.xml"/>
 <o:File HRef=3D"props006.xml"/>
 <o:File HRef=3D"item0007.xml"/>
 <o:File HRef=3D"props008.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"image001.png"/>
 <o:File HRef=3D"image002.png"/>
 <o:File HRef=3D"image003.png"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D7475B.26890930--
